Computationally Guided Design of a Readily Assembled Phosphite- Thioether Ligand for a Broad Range of Pd-Catalyzed Asymmetric Allylic Substitutions by Biosca, M et al.
1 
 
Computationally Guided Design of a Readily Assembled Phosphite–
Thioether Ligand for a Broad Range of Pd-Catalyzed Asymmetric 
Allylic Substitutions 
Maria Biosca,a Jèssica Margalef,a Xisco Caldentey,b Maria Besora,b,* Carles Rodríguez-
Escrich,b Joan Saltó,a Xacobe C. Cambeiro,b Feliu Maseras,b,* Oscar Pàmies,a,* Montserrat 
Diéguez,a,*  Miquel A. Pericàs,b,c,* 
a Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/ Marcel·lí 
Domingo, s/n., 43007 Tarragona, Spain. Fax: (+34)977559563; Tel: (+34)977558780; email: 
montserrat.dieguez@urv.cat 
b Institute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and 
Technology, Av. Països Catalans 16, 43007 Tarragona, Spain. Fax: (+34)977920244; Tel: 
(+34)977920200; email: mapericas@iciq.es. 
c Departament de Química Orgànica. Universitat de Barcelona. 08028 Barcelona, Spain. 
 
Abstract 
A modular approach employing indene as the common starting material has enabled the 
straightforward preparation (in three reaction steps) of a set of ligands for the palladium-
catalyzed asymmetric allylic substitution. The optimization of the first generation ligand 
library on the basis of rational design and theoretical calculations has provided an 
anthracenethiol- derivative that displays excellent behavior in the reaction of choice. 
Improving most approaches reported to date, this streamlined ligand presents a broad 
substrate and nucleophile scope. Excellent enantioselectivities have been therefore achieved 
for a range of linear and cyclic allylic substrates using a large series of C-, N- and O-
nucleophiles (40 examples in total). The species responsible for the catalytic activity have 
been further investigated by NMR and the origin of the enantioselectivity have been clearly 
established. The resulting products have been derivatized by means of ring-closing metathesis 





The future of chemical production must keep up with the growing demand for fine 
chemicals while reducing the overall waste production and energy consumption demanded by 
international regulations (and common sense). Over the last decades, this need for 
sustainability has driven the shift from suboptimal non-catalyzed processes to high-
performing catalytic processes for the production of all sorts of chemicals.1 This has been 
especially noteworthy in the production of enantiopure compounds, which play a key role in 
many technologically and biologically relevant applications.2 Amongst the toolkit of catalytic 
enantioselective transformations, asymmetric Pd-catalyzed allylic substitution stands out for 
its versatility (as it creates new C-C and C-heteroatom bonds starting from simple precursors), 
high functional group tolerance and mild reaction conditions. Moreover, the resulting 
products accept further derivatization thanks to the presence of an alkene functionality.3 The 
key role of the ligand in the induction of chirality in this process has motivated several studies 
concerning the generation and evaluation of myriad candidates in terms of yield, selectivity 
and substrate scope. Heterodonor compounds (phosphine/phosphinite-oxazolines being the 
paradigmatic example) have proven especially advantageous because the different trans 
influence of the two donor groups generates an efficient electronic differentiation between the 
two allylic terminal carbon atoms. Indeed, the nucleophilic attack is known to take place 
predominantly trans to the donor group with stronger trans influence. On the basis of this 
premise, we have contributed with mixed ligands bearing biaryl phosphite moieties,3j,4 which 
flexible nature allows the catalyst chiral pocket to adapt to the steric demands of the 
substrate4e and , therefore, they have significantly broaden the substrate scope.   
The vast amount of Pd-catalyzed allylic substitution studies reported in the literature might 
give the wrong impression that this is a mature field. However, despite the remarkable 
advances in catalyst design, ligands are still rarely suitable for a wide range of substrates. 
Instead, the most common scenario is that each allylic precursor requires independent 
optimization to identify the optimal catalytic system, and a similar situation takes place with 
the various nucleophiles. Consequently, the identification of “privileged” ligands remains a 
central task in this type of chemistry. In addition to giving excellent results for a broad range 
of allylic precursors and nucleophiles (C, N or O-based), such privileged ligands must be 
readily prepared from available starting materials and be easy to handle (i.e. solid, robust and 
stable in air).  
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To this end, we recently started a research line aimed at identifying suitable alternatives to 
the labile oxazoline moiety. We were especially interested in the stable and easy to prepare 
thioether group, which allowed the preparation of a Pd/phosphite-thioether furanoside-based 
catalyst that creates C-C, C-N and C-O bonds with different substrates and a variety of 
nucleophiles.5 The yields and enantioselectivities obtained were comparable to the best 
catalytic systems reported in the literature. Although these furanoside ligands were prepared 
from inexpensive D-Xylose, their synthesis was tedious and required a large number of steps. 
Other researchers have demonstrated the utility of thioether-based P-S ligands.6 For instance, 
the pioneering work in Pd-catalyzed allylic substitution and other relevant asymmetric 
reactions of Pregosin7 and Evans,6a among others, put the focus on this kind of ligands and 
spurred their development. Despite the many efforts devoted to develop P-S ligands, their 
impact has been limited for two main reasons: (a) even in the most successful cases, they 
were limited in substrate and nucleophile scope: enantioselectivities were mainly high for the 
allylic substitution of the standard (and hindered) rac-1,3-diphenyl-3-acetoxyprop-1-ene S1 
using dimethylmalonate as nucleophile,6 and (b) thioether-based ligands are prone to 
producing mixtures of diastereomeric thioether complexes, which tend to interconvert in 
solution.8 However, if one could design a scaffold able to control the S-coordination of the P-
S ligand, the chiral element would move closer to the metal, thus giving rise to simpler 
ligands that can be prepared in less steps than their oxazoline-phosphine counterparts.  
Herein, we give a new push to the study of the catalytic potential of P,S-ligands by 
screening readily accessible but novel thioether-containing compounds, including a detailed 
study of the species responsible for the catalytic performance. For this purpose, we designed a 
small but structurally diverse library of P-thioether ligands L1–L8a–g (Figure 1) that was 
tested in the Pd-catalyzed allylic substitution of a broad range of substrates and nucleophiles. 
These new P,S-ligands are synthesized in only three steps from inexpensive indene (ca. 20 
USD/kg in bulk) and, since the corresponding enantiopure epoxide is prepared through 
Jacobsen epoxidation, both enantiomeric series are equally available. This modular approach9 
greatly expedites the evaluation of several thioether and phosphite/phosphinite moieties, 
which is deemed crucial for the iterative optimization of the most promising candidates. 
Consequently, the catalytic performance of the ligands depicted in Figure 1 has been studied 
by systematically varying: (i) the electronic and steric properties of the thioether (L1–L8) 
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group, (ii) the configuration of the biaryl phosphite moiety (a–c), and (iii) the P-containing 
group (phosphite versus phosphinite groups, d–g).   
 
Figure 1. Phosphite/phosphinite-thioether ligand library L1–L8a–g. 
 
An additional advantage of this set of ligands is the fact that their simplified backbone 
renders very simple NMR spectra, thus reducing signal overlap, as well as facilitating the 
identification of relevant intermediates and accelerating the DFT calculations performed to 
rationalize the behavior of the system. By combining theoretical studies and NMR 
spectroscopy, we have been able to rationally fine-tune the ligands, improve 
enantioselectivity and identify the species responsible for the catalytic performance. This 
optimized ligand has proven active in the Pd-catalyzed allylic substitution of both linear and 
cyclic substates with a broad range of C-, N-, and O-nucleophiles (26 examples in total), 
even with the environmentally friendly propylene carbonate as solvent. Finally, the 
applicability of the new Pd/P-thioether catalysts has been further demonstrated in the 
practical synthesis of chiral (poly)carbocyclic and heterocycles using straightforward 
sequences of allylic alkylation/ring-closing metathesis or allylic alkylation/Pauson-Khand 
reactions.  
 
2. Results and discussion 
 
2.1. Synthesis of the first generation ligand library L1-L7a-g 
Phosphite/phosphinite-thioether ligands L1–L7a–g can be efficiently prepared in three 
steps as illustrated in Scheme 1. In the first step, epoxidation of inexpensive indene 1 with 
bleach using Jacobsen's catalyst, followed by low-temperature crystallization, yielded indene 
oxide with 99% ee.10 Next, the regio- and stereospecific ring opening of 2 with the 
corresponding thiol was carried out with sodium hydroxide in a dioxane/water mixture.11 In 
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order to ensure chemical diversity, eight thiols with markedly different steric and electronic 
properties were used at this stage. Finally, we took advantage of the hydroxy group in 3–9 to 
establish a representative set of phosphite and phosphinite moieties following standard 
procedures.12 The resulting enantiopure ligands were isolated in good yields as white solids 
(phosphite-thioether ligands L1–L7a–c) or colorless oils (phosphinite-thioether ligands L1–
L7d–g). Phosphite-thioether ligands were found to be stable in air and resistant to hydrolysis, 
whereas the phosphinite analogues, proved less stable, slowly decomposing after a month 
even when stored at low temperature.   
 
 
Scheme 1. Three-step synthesis of phosphite/phosphinite-thioether ligands L1–L7a–g from 
indene. (i) (R,R)-Mn-salen catalyst, 4-PPNO, aq. NaClO, CH2Cl2;
10 (ii) RSH, NaOH, 
dioxane/H2O (10:1);
11 (iii) ClP(OR1R2)2; (OR




g, NEt3, toluene. 
 
All ligands were characterized by 31P{1H}, 1H and 13C{1H} NMR spectroscopy and 
HRMS. All data were in agreement with assigned structures.i  See experimental section for 
purification and characterization details.  
 
2.2. Evaluation of the first generation ligand library in the allylic substitution of 
symmetrical 1,3-disubstituted allylic substrates 
                                                 
i The spectra assignments were supported by the information obtained from 1H–1H and 1H–13C correlation 
measurements. The 31P{1H}, 1H and 13C{1H} NMR spectra showed the expected pattern for the C1–ligands. The 
VT-NMR in CD2Cl2 (+35 to –85 °C) spectra showed only one isomer in solution. In all cases, one singlet in the 




As already mentioned, the catalyst ability to adjust to the steric demands of the substrate is 
a key factor in transferring the chiral information to the product. To assess the potential of this 
ligand library in the allylic substitution, we first tested L1–L7a–g in the Pd-catalyzed allylic 
substitution of two substrates with different steric requirements: the model substrate S1 and 
the more challenging cyclic S2 (Table 1). Excellent yields were almost invariably obtained 
under mild reaction conditions (i.e. 1 mol% Pd, ligand-to-palladium ratio of 1.1 at room 
temperature) with TOF as high as 2000 mol (mol h)–1. As for the enantioselectivities, up to 
97% ee for S1 and 88% ee for S2 could be achieved by using ligands that combine an aryl 
thioether group with a chiral biaryl phosphite moiety.  
In an effort to measure the contribution of the different P-donor groups, we analyzed the 
results of ligands L1a–g (entries 1-7). The trend was clearly pointing out to a superior 
performance of phosphite- over phosphinite-based structures (i.e. entries 2 vs. 4-7), even with 
very bulky ones. The possibility that chirality of the ligand could control the conformation 
around the biphenyl moiety was ruled out by comparing entries 1-3, where the superior 
performance of ligands bearing a phosphite with axial chirality was evident (entries 2-3). 
Actually, the chiral axis seems to be the major factor in controlling the enantioselectivity. 
Indeed, ligands differing only in the configuration of this chiral axis (but otherwise having the 
same stereocenters) give rise to products with opposite absolute configuration (entries 2-3). 
Considering the substrates independently, with S1 a remarkable cooperative effect between 
the configuration of the biaryl phosphite moiety and the ligand backbone is observed, which 
results in a matched combination with ligand L1b, that bears an (R) chiral axis (entry 2 vs 3). 
This cooperative effect is less pronounced for cyclic substrate S2, and both enantiomers of the 
alkylated products are therefore easily accessible with similar levels of enantioselectivity by 
simply setting the configuration of the biaryl phosphite moiety (entry 2 vs 3).   
Finally, by further comparing ligands L1–L7b, we found that the electronic and steric 
properties of the thioether substituent have a small but important effect on the 
enantioselectivities: ligands with aryl-thioether groups led to higher ee’s (especially with 
cyclic substrate S2; i.e. entry 11 vs 2, 8 and 9) than their counterparts with alkyl thioether 
moieties, even for the bulky tert-butyl thiol derivative. In summary, the best 
enantioselectivities for S1 (ee's up to 97%) were obtained with ligands L4–L7b, built from a 
combination of any aryl thioether group with an R-biaryl phosphite group: the above-
7 
 
mentioned matched combination (entries 11, 12, 16 and 17). On the other hand, the best 
enantioselectivities recorded for substrate S2 (ee's up to 88%), in both enantiomers of the 
alkylated product, were obtained with ligands L4–L7b–c, containing either an R or S-biaryl 
phosphite group with an aryl thioether moiety (i.e. entries 11–13 and 16–17). 
With the aim of improving the sustainability profile of the process, we studied the 
reactions in 1,2-propylene carbonate (PC), an environmentally friendly alternative to standard 
organic solvents because of its high boiling point, low toxicity, and "green" synthesis.13 
However, it has been scarcely used in asymmetric Pd-catalyzed allylic substitution and mainly 
limited to the standard S1 substrate and dimethyl malonate as nucleophile.4d,13b,14 Thus, we 
repeated the allylic substitution of substrates S1 and S2 in PC (Table 1, entry 18; see also 
Table SI-1 in the Supporting Information for the use of PC for the allylic substitution of other 
substrates and nucleophiles). Gratifyingly, the enantioselectivities remained as high as those 




Table 1. Pd-catalyzed allylic alkylation of S1–S2 with dimethyl malonate as nucleophile 






Entry L % Conv (h)b %eec  % Conv (h)b %eec 
1 L1a 100 (0.5) 17 (R)  100 (2) 15 (S) 
2 L1b 100 (0.5) 90 (R)  100 (2) 66 (R) 
3 L1c 100 (0.5) 75 (S)  100 (2) 61 (S) 
4 L1d 100 (0.5) 50 (R)  100 (2) 28 (S) 
5 L1e 100 (0.5) 25 (R)  100 (2) 11 (S) 
6 L1f 5 (0.5) 32 (R)  10 (2) 28 (S) 
7 L1g 100 (0.5) 4 (R)  100 (2) 14 (R) 
8 L2b 100 (0.5) 90 (R)  100 (2) 62 (R) 
9 L3b 100 (0.5) 84 (R)  100 (2) 60 (R) 
10 L3e 100 (0.5) 63 (R)  100 (2) 77 (S) 
11 L4b 100 (0.5)d 97 (R)  100 (2) 85 (R) 
12 L5b 100 (0.5) 96 (R)  100 (2) 86 (R) 
13 L5c 100 (0.5) 80 (S)  100 (2) 84 (S) 
14 L5d 100 (0.5) 28 (R)  100 (2) 13 (S) 
15 L5e 100 (0.5) 40 (R)  100 (2) 11 (S) 
16 L6b 100 (0.5) 96 (R)  100 (2) 88 (R) 
17 L7b 100 (0.5) 97 (R)  100 (2) 87 (R) 
18e L5b 100 (1) 96 (R)  100 (4) 85 (R) 
a 0.5 mol% [PdCl(η3-C3H5)]2, ligand (0.011 mmol), substrate (1 mmol), CH2Cl2 
(2 mL), BSA (3 equiv), nucleophile (3 equiv), KOAc (pinch) at rt. b Conversion 
measured by 1H NMR. c Enantiomeric excesses measured by HPLC for dimethyl 
2-(1,3-diphenylallyl)malonate (10) and by GC for dimethyl 2-(1,3-
cyclohexanylallyl)malonate (11). d TOF= 2000 mol (mol h)-1 calculated after 5 
min from catalysis performed at 0.25 mol% of Pd. e Reactions carried out using 





2.3. Optimization of ligand parameters by DFT computational studies leading 
to fine-tuned phosphite-thioether ligands L8 
 
With the ultimate goal of fine-tuning the ligands to increase enantioselectivity, we carried 
out DFT calculations of the transition states and key Pd-olefin intermediates involved in the 
enantiodetermining step. Previous mechanistic studies on Pd-catalyzed allylic alkylation have 
established the irreversible nucleophilic attack as the enantiodetermining step, although the 
corresponding transition state (TS) can be either early or late, depending on the nucleophile, 
ligands, and reaction conditions.15 In the latter case, the enantioselectivity of the final product 
is controlled by the formation of the most stable Pd-olefin complex, rather than by the 
difference in energy of the transition states leading to products. 
Therefore, we started by calculating the relative stability of the transition states and the Pd-
olefin intermediates using the model substrate S1 and dimethyl malonate as nucleophile with 
ligands L5b–c. The goal was to evaluate the effect of the chiral axis of the biaryl phosphite 
moiety, as these ligands differ only in the configuration of this biaryl (see Table 1, entry 12 vs 
13). Only the two syn-syn allyl complexes were calculated, neglecting the contribution of 
other allylic species of higher energy (anti-anti and syn-anti).3d In this study, we have taken 
into account the configuration of the thioether and the attack of the nucleophile trans to P and 
S atoms. In contrast to P-N ligands, the trans effect exerted by the thioether and the phosphite 
are of a similar magnitude; indeed, previous studies have shown that small changes in the 
ligand can shift the trans preference in P,S-ligands.5b,16 The results of the most stable 
transition states (TS(R) and TS(S)) and Pd-olefin intermediates (Pd-olefin(R) and Pd-olefin(S)) 
leading to the formation of both product enantiomers are shown in Table 2 (the full set of 
calculated TSs and Pd-olefin intermediates can be found in the Supporting Information). The 
energy differences of the calculated TSs match with the results obtained in the catalytic 
process, the value for L5b (ΔG#= 28 kJmol-1; eecalc > 99% (R)) being therefore higher than 
that of L5c (ΔG#= 10.8 kJmol-1; eecalc = 97% (S)). This is in agreement with the higher 
enantioselectivities achieved using L5b than L5c (96% (R) ee for L5b vs 80% (S) ee for L5c; 
Table 1, entries 12 and 13). Moreover, DFT correctly predicts the formation of the opposite 
product enantiomers when L5b and L5c are applied. It should be noted that, in contrast to 
what was observed with ligand L5b, both enantiomers of the substitution product obtained 
with ligand L5c arise from TSs with exo coordination of the substrate, with the nucleophilic 
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attack trans to P (for the major enantiomer) and trans to S (for the minor enantiomer). Finally, 
the calculated energies of the Pd-olefin intermediates do not correlate well with the 
experimental results (Table 2). For both ligands, the most stable olefin complex corresponds 
to the R-enantiomer in more than 99% ee. The enantioselectivity is therefore not controlled by 
the rotation of the allylic system during the nucleophilic attack leading to the most stable 
Pd(0)-olefin complex.  
Table 2. Calculated energies for the most stable transitions 
states (TS) and Pd-π-olefin complexes leading to the R- and S- 
enantiomers of the alkylated product of S1 using dimethyl 
malonate as nucleophile.  
Transition states (TS) 
Ligand TS(R) TS(S) % eecalc % eeexp 
L5b 
  
>99 (R) 96 (R) 
L5c 
  
96 (S) 80 (S) 
Pd-olefin complexes 
Ligand Pd-olefin(R) Pd-olefin(S) % eecalc % eeexp 
L5b 
  





>99 (R) 80 (S) 
E= CO2Me 
 
Of all transition states (TSs) evaluated for both ligands, L5b and L5c, Figure 2 shows the 
two most stable. For the Pd/L5b catalytic system, it is seen that the endo TS is destabilized 
due to steric repulsion between one of the phenyl substituents of the substrate and the biaryl 
phosphite moiety. This increases the energy gap between the endo and exo TSs and could 
explain the preference for one of the pathways and, consequently, the higher enantiomeric 
excess achieved with Pd/L5b compared to Pd/L5c. In the Pd/L5c catalyst, this repulsion is 
less pronounced and therefore the two TSs have a more similar energy. The different steric 
constrains between both catalytic systems are reflected by the dihedral angles ω1-ω3 (Figure 
2). Thus, the difference between the dihedral angles ω1(C-O1-P-Pd) and ω3(C-O1-P-O2) of the 
TSs responsible for the formation of the R- and S-enantiomers (TS(R) and TS(S)) are higher for 
Pd/L5b than for Pd/L5c catalytic systems. It is also interesting to note the different spatial 
arrangement of the hydrogens of the methylene group of the ligand backbone. In the TSs of 
Pd/L5c the hydrogens are closer to the phosphite moiety than in the TSs of Pd/L5b, making 
the steric environment where the substrate is located less crowded. This again supports that 
the energy differences between the TSs are closer in Pd/L5c than in Pd/L5b. 
Finally, we divided the energies of the transition states in: deformation energies of two 
moieties ([Pd-L5] and [substrate-nucleophile]) and in interaction energy between the two 
moieties. The results show very similar interaction energies for both ligands, but larger 
deformation energy for the [Pd/L5b] moiety than for [Pd/L5c]. This goes in line with 
previous findings showing that the transition states with L5c can accommodate better the 






Figure 2. Most stable calculated transition states from S1 using ligands (a) L5b and (b) L5c 
(hydrogen atoms have been omitted for clarity). 
 
Based on the previous findings, we investigated whether the lower enantiomeric excesses 
recorded with the cyclic substrate S2 (ee’s up to 88%) could be improved by increasing the 
steric hindrance of the ligand. A simple way to do this is to introduce a thioether group that is 
bulkier than the 2,6-dimethylphenyl moiety, while maintaining the aryl groups (that have been 
shown to perform better than their alkylic counterparts). For this purpose, we ran analogous 
TS calculations for S2 with ligand L5b (bearing the 2,6-dimethylphenyl thioether group) and 
with other ligands containing instead the bulkier 2,6-diisopropylphenyl or anthracenyl 
moieties. To accelerate the DFT calculation we used ammonia as model nucleophile.17 The 
results show that the enantioselectivity is affected by the steric effects of the thioether group 
(Table 3), increasing from 9% (R) for ligand L5b (with a 2,6-dimethylphenyl thioether group) 
to 35% with a 2,6-diisopropylphenyl thioether, and to 74% (R) with an anthracenyl thioether 
moiety. The results of these calculations prompted us to prepare two new ligands containing 
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an anthracenyl thioether group (L8b and L8c; Figure 1)ii and test them in the Pd-catalyzed 
alkylation of S2. To our delight, the introduction of this bulky aromatic moiety did affect 
positively the enantioselectivity, increasing from 86% ee to 94% ee (Table 3), as predicted by 
the theoretical calculations. This result is comparable to the best one reported in the literature 
for this challenging substrate.3 If we compare the calculated and experimental values (Table 
3), we can conclude that, despite the fact that the calculated free energy differences are 
systematically lower than the experimental values, the general trend is reproduced well. The 
robustness of the theoretical model is demonstrated with the prediction of the new improved 
ligands L8b,c containing an anthracenyl moiety. Interestingly, ligand L8b also provided the 
highest enantioselectivity in the alkylation of linear substrate S1 (ee’s up to 99% (R), 
compared to previous best value 97% with ligand L7b). 
 
Table 3. Comparison between theoretical 
and experimental results in the Pd-catalyzed 
allylic substitution of S2.  




L5b 1.2 kJ/mol 9 (R) 86 (R) 6.3 kJ/mol 
 
- 2.1 kJ/mol 35 (R) - - 
 
L8b 6.8 kJ/mol 74 (R) 94 (R)b 8.6 kJ/mol 
a Reaction conditions: 0.5 mol% [PdCl(η3-C3H5)]2, ligand (0.011 mmol), 
substrate (1 mmol), CH2Cl2 (2 mL), BSA (3 equiv), nucleophile (3 equiv), KOAc 
(pinch) at rt. b Ligand L8c provided the alkylated product 12 in 93% ee (S). 
 
  
                                                 
ii These ligands were prepared from (1S,2S)-1-(anthracen-9-ylthio)-2,3-dihydro-1H-inden-2-ol (12) as described 
in Scheme 1. 
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2.4. Allylic substitution of linear substrate S1 with several nucleophiles. Scope and 
limitations 
 
We initially considered the allylic substitution of substrate S1 with an extensive range of 
C-, N- and O-nucleophiles. Table 4 shows the results using ligand L8b, which had provided 
the best results in the allylic alkylation of S1 with dimethyl malonate as model nucleophile. A 
variety of malonates, including the allyl-, butenyl-, pentenyl- and propargyl-substituted ones, 
reacted with S1 to provide products 13–19 in high yields and enantioselectivities (ee's up to 
99, entries 1–7). These substituted malonates are known to be more challenging nucleophiles 
for Pd-catalyzed allylic substitution, but they give rise to more interesting products from a 
synthetic point of view (see section 2.6 below). The addition of acetylacetone also proceeded 
with high enantiocontrol (entry 8, ee's up to 98%). High yields and enantioselectivities were 
also found in the addition of malononitrile and isopropyl cyanoacetate (products 21 and 22; 
ee's up to 99%, entries 9 and 10) albeit the diastereoselectivity of the latter was low, as 
expected for such an acidic stereocentre.18  
Pyrroles, which are electron-rich N-containing heterocycles interesting from the synthetic 
and biological point of view,19 also performed well as nucleophiles in this reaction. Despite 
their importance, only one catalytic system has been successful in the Pd-catalyzed allylic 
alkylation of S1 type substrates with pyrroles, and this only at low temperature (–20 ºC).20 
The difficulty of the transformation is more evident if we consider that, even two of the most 
successful ligands developed for this process (Trost diphosphine and phosphine-oxazoline 
PHOX), did not work with pyrroles.20 Thus, we were pleased to see that using the Pd/L8b 
system we could reach ee's up to 99% and high yields working at room temperature (entries 
11 and 12). 
Chiral allylic amines are also ubiquitous in biologically active compounds,3n so we next 
studied the use of amine derivatives as nucleophiles. Benzylamine provided the substitution 
product 25 in high yield and enantioselectivity (99% ee; entry 13). To test the scope of allylic 
amination, the reaction of S1 was evaluated using other N-nucleophilic compounds (entries 
14–18). The combination Pd/L8b also proved highly efficient in the addition of p-methoxy- 
and p-trifluoromethylbenzylamines (compounds 26 and 27) and the furfurylamine 28 (entries 
14–16), enantiocontrol being always excellent. The addition of morpholine, a cyclic 
secondary amine, also gave the expected product with high enantioselectivity (product 29; 
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entry 17), while allylamine proceeded with comparably high enantioselectivity (97% ee; entry 
18). This is especially interesting given the fact that the amination product 30 is a key 
intermediate in the synthesis of complex molecules. For example, the Boc protected 
derivative of 30 can be further applied in metathesis reactions for the construction of a 
dihydropyrrole derivative (see section 2.6 below).  
The exquisite enantiocontrol observed for C- and N-nucleophiles can also be extended to 
aliphatic alcohols (compounds 31–35, ee's up to 99%; entries 19–23). The effective allylic 
substitution with this type of O-nucleophiles opens up new synthetic avenues towards chiral 
ethers, which are important for the synthesis of biologically active molecules.21 Despite the 
potential of the resulting products, a general catalytic solution for the Pd-catalyzed allylic 
etherification has remained elusive and most of the few successful examples reported to date 
deal with phenols,22 while aliphatic alcohols have been less studied.4e,6a,23 Moreover, the 
enantioselectivities reported so far largely depend on the type of aliphatic alcohol and small 
modifications of their electronic properties4e,6a,23 can have a large impact on this parameter. 
Using our streamlined ligand L8b, we found that benzylic alcohols gave excellent results 
regardless of the steric and electronic properties of the aryl group (entries 19–22). Allyl 
alcohol also furnished the desired product in high yield, and ee (entry 23). Even more 
outstanding are the almost perfect enantioselectivities (ee's up to 99%) and high yields 
achieved in the etherification of S1 with triphenylsilanol (entry 24), a rather unusual 
nucleophile that gives rise to a protected chiral alcohol.23e Remarkably, enantioselectivities 
recorded with O-nucleophiles (entries 19–24) were, at the very least, as high as those obtained 





Table 4. Pd-catalyzed allylic substitution of linear substrate S1 with different types of C, N, 
and O nucleophiles using Pd/L8b catalytic system.a 
 
Entry Substrate Product % Yieldb % eec Entry Substrate Product % Yieldb % eec 
1 S1 
 
94 99 (R) 13 S1 
 
88 99 (S) 
2 S1 
 
92 98 (R) 14 S1 
 
81 99 (S) 
3 S1 
 
92 97 (S) 15 S1 
 
78 99 (S) 
4 S1 
 
93 98 (S) 16 S1 
 
83 97 (S) 
5 S1 
 
89 98 (S) 17 S1 
 
87 98 (S) 
6 S1 
 
91 95(S) 18 S1 
 
79 97 (S) 
7 S1 
 
90 99 (S) 19e S1 
 
92 99 (S) 
8 S1 
 
88 98 (R) 20e S1 
 
90 99 (S) 
9 S1 
 
84 99 (R) 21e S1 
 






98/97d 22e S1 
 
93 98 (S) 
11d S1 
 
87 96 (S) 23e S1 
 
83 96 (S) 
12d S1 
 
85 >99 (S) 24e S1 
 
78 99 (R) 
a 0.5 mol% [PdCl(η3-C3H5)]2, 1.1 mol% ligand, CH2Cl2 (2 mL), BSA (3 equiv), nucleophile (3 equiv), KOAc 
(pinch) at rt for 30 min. b Isolated yield. c Enantiomeric excesses measured by HPLC or GC. d 2 mol% [PdCl(η3-
C3H5)]2, 4.4 mol% ligand CH2Cl2 (2 mL), K2CO3 (2 equiv) at rt for 18 h. e 2 mol% [PdCl(η3-C3H5)]2, 4.4 mol% 
ligand CH2Cl2 (2 mL), Cs2CO3 (3 equiv) at rt for 18 h. 
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2.5. Allylic substitution of several linear and cyclic substrates S2–S9 using several C-
nucleophiles. Scope and limitations 
 
After the broad scope of nucleophiles displayed by the catalytic system with S1, we turned 
our attention to the use of another five linear substrates (S3–S7) with electronic and steric 
requirements different from S1 (Table 5, entries 1–6). Advantageously, we found that the 
catalytic performance was neither affected by the introduction of electron-withdrawing and 
electron-donating groups (entries 1–3), nor by the introduction of ortho- and metha-
substituents at the phenyl groups of the substrate (entries 4–5). A remarkable 
enantioselectivity (entry 6) was still achieved in the Pd-catalyzed allylic alkylation of S7, a 
challenging substrate that typically gives rise to the corresponding substitution products in 
much lower enantioselectivities than S1 in otherwise identical conditions. 
Finally, we wanted to see if the high enantioselectivities achieved in the allylic substitution 
of linear substrates were retained for their notoriously difficult cyclic analogues. To this end, 
a number of cyclic substrates with different ring sizes were tested using ligand L8b (Table 5; 
for the results using the Pd/L8c catalytic system see Table SI.2 in the Supporting 
Information). For substrate S2, a range of C-nucleophiles proved to give yields and 
enantioselectivities as high, if not higher, as those recorded with dimethyl malonate (ee's up to 
97%, entries 7–11). The only exception was acetylacetone that led to somewhat lower 
enantioselectivity (entry 6). High enantioselectivities in both enantiomers of the substitution 
products were thus obtained using methyl-, allyl- and propargyl-substituted malonates 
(compounds 45–47; Table 5; entries 9–11 and Table SI.2). Furthermore, the biaryl phosphite 
group in Pd/L8b and Pd/L8c can adapt its chiral pocket to efficiently mediate the substitution 
of other cyclic substrates (entries 13–16). Excellent yields and enantioselectivities, 
comparable to the best reported in the literature, were obtained in the allylic alkylation of a 7-
membered cyclic substrate with different C-nucleophiles (products 51 and 52; entries 15 and 
16). Even more interesting is that the good performance could be also extended to the allylic 
alkylation of a more challenging 5-membered cyclic substrate (compounds 49 and 50; entries 





Table 5. Pd-catalyzed allylic substitution of substrates S2–S9 with several C nucleophiles 
using Pd/L8b catalytic system.a 
 
Entry Substrate Product % 
Yieldb 





98 98 (R) 9 S2 
 
87 91 (R) 
2 S3 
 
87 97 (R) 10 S2 
 
84 94 (R) 
3 S4 
 
89 96 (R) 11 S2 
 
86 97 (R) 
4 S5 
 
91 97 (R) 12 S2 
 
82 80 (-) 
5 S6 
 
87 99 (R) 13 S8 
 







83 85 (-) 
7 S2 
 
87 95 (R) 15 S9 
 
90 96 (R) 
8 S2 
 
84 95 (R) 16 S9 
 
92 96 (R) 
a 0.5 mol% [PdCl(η3-C3H5)]2, 1.1 mol% ligand, CH2Cl2 (2 mL), BSA (3 equiv), nucleophile (3 equiv), KOAc 
(pinch) at rt for 2 h. b Isolated yield. c Enantiomeric excesses measured by HPLC, GC or 1H-NMR using 
[Eu(hfc)3]. 
 
2.6 Synthetic applications of the allylic substitution compounds. Preparation of chiral 
functionalized (poly)carbocyclic and heterocyclic compounds 53–61 
 
To illustrate the synthetic versatility of the compounds obtained from the enantioselective 
Pd-catalyzed allylic substitution, we have prepared a range of chiral functionalized 
carbocycles (53–56), heterocycles (57–58) and polycarbocycles (59–61). These compounds 
have been synthesized by straightforward reaction sequences involving allylic substitution of 
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the substrate followed by either ring-closing metathesis (Scheme 2) or Pauson-Khand enyne 
cyclization (Scheme 3). 
According to this strategy, the alkylated compounds 16–18 (see Table 4 above) undergo 
clean ring-closing metathesis with no loss of enantiopurity, furnishing a number of 5, 6 and 7-
membered carbocyles, in high yields and enantioselectivities (ee’s ranging from 95–98%; 
Scheme 2). In an analogous manner, the O-heterocycle (S)-57 is achieved by sequential allylic 
etherification of S1 with allylic alcohol and ring-closing metathesis reaction (Scheme 2); the 
corresponding N-heterocycle 58 performs similarly, albeit it requires protection of the amine 
with Boc prior to the ring-closing metathesis reaction, due to the azophilicity of ruthenium.  
 
 
Scheme 2. Preparation of chiral functionalized carbo- and heterocyclic compounds 53–58.  
 
The second derivatization we tackled was the Pauson-Khand reaction of the propargylated 
derivatives 47, 50 and 52 (see Table 5 above), which differ only in the size of the ring. 
Formation of the complex with Co2(CO)8, followed by thermal decomposition, gave rise to 
the [2+2+1] cycloadducts 59–61, which feature an architecturally complex tricyclic system 
with a trans-cis fusion (Scheme 3). Remarkably, the chiral information on the allylic 
substitution products was reliably conveyed to the final products, which were isolated as 
single diastereomers and with ee’s replicating those of the starting materials. The relative 
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configuration of ketone 61 was assigned on the basis of a single crystal X-ray diffraction 
image, 59 and 60 being assigned by analogy. 
  
 
Scheme 3. Preparation of chiral functionalized polycarbocyclic compounds 59–61. X-ray 
structure of compound 61 is also included.  
 
2.7. Origin of enantioselectivity: study of the Pd--allyl intermediates 
 
Our DFT calculations have established the nucleophilic attack as the enantiodetermining 
step (vide supra). With the aim of better understanding the catalytic process, we decided to 
prepare and characterize the Pd-allyl intermediates and determine their relative reactivity 
towards the nucleophile. Consequently, we studied the Pd--allyl compounds 62–65 [Pd(3-
allyl)(L)]BF4 (L = L5b–c) by NMR and DFT studies. These Pd-intermediates containing 
cyclohexenyl and 1,3-diphenyl allyl groups were synthesized as previously reported (Scheme 
4).24 All complexes were characterized by 1H, 13C and 31P NMR spectroscopyiii and mass 
spectrometry. Unfortunately, we were unable to obtain crystal of sufficient quality to perform 
                                                 
iii The spectral assignments were confirmed using 1H-1H, 31P-1H, 13C-1H and 1H-1H NOESY experiments as well 
as DFT calculations. 
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X-ray diffraction measurements. The ESI-HR-MS showed the heaviest ions at m/z 
corresponding to the cation. 
 
 
Scheme 4. Preparation of [Pd(3-allyl)(L)]BF4 complexes 62–65. 
 
To understand why the opposite enantiomer is obtained when changing the configuration 
of the biaryl phosphite group, we compared the Pd-1,3-cyclohexenyl-allyl intermediate 62, 
which contains ligand L5b with its related counterpart Pd/L5c intermediate (63). The VT-
NMR study (30 ºC to –80 ºC) showed the presence of essentially single isomers (ratio ca. 
20:1; Scheme 5) for both intermediates (62 and 63). The major isomers were unambiguously 
assigned by NMR to be the exo isomer for 62 and the endo isomer for 63. In both cases, the 
thioether group had an S-configuration. For complex 62, the NOE indicated interactions 
between one of the tert-butyl groups of the phosphite moiety with the terminal allyl proton 
trans to the thioether group, whereas for compound 63 this interaction appeared with the 
methinic hydrogen of the CH-O group (Figure 2). The exo arrangement of the allyl group in 
complex 62 is further confirmed by a NOE interaction of the terminal allyl proton trans to the 
phosphite moiety with one of the methyl groups of the thioether moiety, while the other 
methyl of the thioether group presents a NOE interaction with the methinic hydrogen of the 
CH-S group (Figure 2). Similarly, the endo disposition of the allyl group in the complex 63 is 
further confirmed by the presence of NOE interactions with one of the methyls of the 2,6-
dimethylphenyl thioether group with the methinic hydrogen of the CH-S group, the central 
allyl proton and the terminal allyl proton trans to the phosphite moiety. The assignments are 
in agreement with the DFT calculations of the Pd-η3-cyclohexenylallyl complexes (see 
Supporting Information for the results of the full set of calculated Pd-η3-allyl intermediates). 
Thus, for Pd/L5b the major Pd-η3-exo isomer is 9.5 kJ/mol more stable than the most stable 
endo isomer, while for Pd/L5c the Pd-η3-endo isomer energy is 7.3 kJ/mol lower than the 
most stable exo isomer. The 13C NMR chemical shifts indicate that for both major isomers the 
most electrophilic allylic terminal carbon is trans to the phosphite group. Assuming that the 
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nucleophilic attack takes place at the more electrophilic allyl carbon terminus, the fact that the 
observed stereochemical outcome of the reaction (86% ee (R) for Pd/L5b and 84% ee (S) for 
Pd/L5c) is similar to the diastereoisomeric excess (de 90%) of the Pd-intermediates indicates 
that both major and minor species react at a similar rate. In summary, the study of Pd-allyl 
intermediates shows that changes in the configuration of the phosphite moiety lead to changes 
in the ratio of the species that provide both enantiomers of the alkylated product. The 




Scheme 5. Diastereoisomeric Pd-η3-allyl intermediates for S2 with ligands L5b and L5c. 
The relative amounts of each isomer are shown in parentheses. The chemical shifts (in ppm) 
of the allylic terminal carbons and the relative DFT-calculated energies are also shown. 
 
 
Figure 2. Relevant NOE contacts from the NOESY experiment of Pd-η3-allyl 




Finally, to assess the impact of the phosphite chiral axis configuration on the 
enantioselectivity obtained for S1, we compared the corresponding Pd allylic intermediates 
with ligands L5b and L5c (64 and 65, respectively). In this case, L5b provided high 
enantioselectivity whereas L5c proved less selective, which is in contrast to the observation 
made for the alkylation of the cyclic substrate S2. The VT-NMR study (30 ºC to –80 ºC) of 
intermediates 64 and 65 showed a mixture of two isomers in equilibrium with ratios 1.3:1 and 
2.3:1, respectively (Scheme 6). All isomers were assigned to be syn/syn, according to the 
NOE interaction between the two terminal protons of the allyl group. Unfortunately, the NOE 
contacts are not conclusive enough to unambiguously assign the 3D structure of these 
isomers. The final assignment of these Pd-allyl intermediates was performed by DFT studies 
(see Supporting Information) and further assessed by studying the reactivity of the Pd-
intermediates with sodium dimethyl malonate at low temperature by in situ NMR studies 
(Figure 3). The DFT calculated population of the different Pd-allyl species (i.e. ratio of 1.4:1 
for complex 64) is in good agreement with the population obtained experimentally. 
Calculations indicate that for both systems, the most stable Pd-allyl intermediate is the exo 
isomer, the endo isomer being higher in energy (0.8 kJ/mol for Pd/L5b and 5.5 kJ/mol for 
Pd/L5c). On the other hand, the reactivity study of the Pd-intermediate 64 with sodium 
dimethyl malonate at low temperature reveals that the minor endo isomer reacts faster than 
the major isomer (Figure 3; kendo/kexo ≈ 8). This reactivity pattern is in agreement with the 
previously presented TS calculations (see Section 2.2), which indicate that the most 
favourable (lowest in energy) transition state arises from the nucleophilic attack to the Pd-
allyl endo intermediate, being the pathway for the exo TS of much higher energy (ΔΔG#= 28 
kJ/mol; Table 2). All these evidences further support the DFT calculations that suggest that 
for intermediates 64 the major isomer has an exo disposition, while the minor isomer has an 
endo spatial arrangement. In contrast, the reactivity study of the Pd-allyl complex 65 indicates 
that the major exo isomer is the isomer that reacts faster with a nucleophile (Figure 3; 
kexo/kendo ≈ 3). Again, this finding is in agreement with the TS DFT calculations (vide supra, 
ΔΔG#= 10.8 kJ/mol, Table 2) and corroborates the DFT isomer assignment of the Pd-allyl 
intermediates observed in solution, having the major isomer an exo arrangement.  
 It should be pointed out that, albeit for the Pd/L5c catalytic system the relative population 
of the faster reacting isomer is much higher than that of Pd/L5b, the latter provides higher 
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enantioselectivity (96% ee for Pd/L5b vs 80% ee for Pd/L5c). Hence, in the case of S1 the 
enantioselectivity seems to be controlled by the different reactivity of the allyl intermediates 
towards the nucleophile (rather than their population, as was the case for S2). These results 
are in line with the previous TS DFT calculations (see section 2.3, Table 2) and therefore 
further corroborate that the energy gap between the most stable TSs leading to each of the 




Scheme 6. Diastereoisomer Pd-η3-allyl intermediates for S1 with ligands L5b and L5c. The 
relative amounts of each isomer are shown in parentheses. The chemical shifts (in ppm) of the 





Figure 3. 31P-{1H}NMR spectra before and after the addition of sodium dimethyl malonate in 
CD2Cl2 at –80 °C of: (a) [Pd(








In summary, following a modular approach from enantiopure indene oxide, a 
phosphite/phosphinite-thioether ligand library has been prepared and benchmarked in the Pd-
catalyzed asymmetric allylic substitution. After careful analysis of these results, and with the 
support of theoretical calculations, we have rationally designed a novel ligand that presents an 
improved enantioselectivity profile. The most remarkable feature of this optimized ligand is 
the broad scope demonstrated: linear and cyclic substrates, as well as a range of C-, N-, and 
O-nucleophiles (40 examples in total), all give rise to the desired products in excellent yields 
and enantioselectivities, even with the green propylene carbonate as solvent. Other advantages 
of the optimized ligand are that it is easily synthesized in only three steps from inexpensive 
indene and that it is solid and stable to air. Thorough mechanistic studies based on NMR 
spectroscopy have led to the identification of the species responsible for the catalytic 
performance, thus rationalizing the origin of the enantioselectivity. For enantioselectivities to 
be high, the ligand parameters therefore need to be correctly combined to either increase the 
difference in population of the possible Pd-allyl intermediates (for cyclic substrates) or to 
increase the relative rates of the nucleophilic attack for each of the possible Pd-allyl 
complexes (linear substrates). To assess the potential impact of this catalytic system in 
synthesis, the products have been employed in ring-closing metathesis or Pauson-Khand 
reactions, giving rise to a set of chiral (poly)carbocycles and heterocycles with retention of the 
enantioselectivity. 
 
4. Experimental section 
4.1. General considerations 
All reactions were carried out using standard Schlenk techniques under an atmosphere of 
argon. Solvents were purified and dried by standard procedures. Phosphorochloridites were 
easily prepared in one step from the corresponding biaryls.25 Enantiopure (–)-indene oxide 210 
and phosphinite-thioether ligands L1d12a and L5d12a were prepared as previously described. 
Racemic substrates S1-S926 and Pd-allyl complexes [Pd(3-1,3-Ph2-C3H3)(-Cl)]2
27 and 
[Pd(3-cyclohexenyl)(-Cl)]2
28 were prepared as previously reported. 1H, 13C{1H}, and 
31P{1H} NMR spectra were recorded using a 400 MHz spectrometer. Chemical shifts are 
relative to that of SiMe4 (
1H and 13C) as internal standard or H3PO4 (
31P) as external standard. 
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1H, 13C and 31P assignments were made on the basis of 1H-1H gCOSY, 1H-13C gHSQC and 
1H-31P gHMBC experiments.  
 
4.2. General procedure for the regio- and stereospecific ring opening of 2. 
Preparation of thioether-alcohols 3-9 and 12  
A solution of (–)-indene oxide 2 (2 mmol, 264 mg) in dioxane (4.5 mL/mmol of indene 
oxide) is treated with the corresponding thiol (3 mmol). Then, a solution of NaOH (3 mmol, 
120 mg) in water (0.45 mL/mmol of indene oxide) is added dropwise. The reaction mixture is 
capped and stirred at 55 C until the epoxide is consumed according to TLC analysis (ca. 45-
60 min). After this, the mixture is cooled to room temperature, diluted with water and 
extracted with CH2Cl2 (3 x 20 mL). The combined organic layers are dried over Na2SO4 and 
concentrated to give a residue that is purified by flash chromatography on silica gel (eluent 
specified in each case) to give the desired thioether-alcohol. 
(1S,2S)-1-(Isopropylthio)-2,3-dihydro-1H-inden-2-ol (3). Yield: 308 mg (74%), white 
solid. SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to 
cyclohexane/EtOAc = 80:20). 1H NMR (400 MHz, CDCl3): δ= 1.34 (d, 3H, CH3, 
iPr, 3JH-H 
=6.7 Hz), 1.38 (d, 3H, CH3, 
iPr, 3JH-H =6.7 Hz), 2.07 (bs, 1H, OH), 2.86 (dd, 1H, CH2,
 2JH-H 
=16.1, 3JH-H =4.4 Hz), 3.14 (hept, 1H, CH, 
iPr, 3JH-H =6.7 Hz), 3.38 (dd, 1H, CH2,
 2JH-H =16.1, 
3JH-H =6.2 Hz), 4.13 (d, 1H, CH-S, 
3JH-H =4.1 Hz), 4.46-4.49 (m, 1H, CH-O), 7.22 (bs, 3H, 
CH=), 7.36 (m , 1H, CH=).13C NMR (100.6 MHz, CDCl3): δ= 23.8 (CH3), 24.2 (CH3), 35.5 
(CH), 39.9 (CH2), 55.9 (CH-S), 79.9 (CH-O), 125.1 (CH=), 125.4 (CH=), 127.1 (CH=), 127.9 
(CH=), 140.0 (C), 141.3 (C). 
(1S,2S)-1-(Propylthio)-2,3-dihydro-1H-inden-2-ol (4). Yield: 325 mg (78%), white solid. 
SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to cyclohexane/EtOAc = 
80:20). 1H NMR (400 MHz, CDCl3): δ= 1.01 (t, 3H, CH3, 
nPr, 3JH-H =7.3 Hz), 1.66 (sext, 2H, 
CH2, 
nPr, 3JH-H =7.3 Hz), 2.10 (bs, 1H, OH), 2.53 (dt, 1H, CH2, 
2JH-H =12.3, 
3JH-H =7.3 Hz), 
2.60 (dt, 1H, CH2, 
2JH-H =12.3, 
3JH-H =7.3 Hz), 2.87 (dd, 1H, CH2,
 2JH-H =16.1, 
3JH-H =4.7 Hz), 
3.37 (dd, 1H, CH2,
 2JH-H =16.1, 
3JH-H =6.3 Hz), 4.09 (d, 1H, CH-S, 
3JH-H =4.3 Hz), 4.49 
(quint, 1H, CH-O, 3JH-H =5.0 Hz), 7.32-7.40 (m, 1H, CH=), 7.20-7.25 (m, 3H, CH=). 
13C 
NMR (100.6 MHz, CDCl3): δ= 13.6 (CH3), 23.2 (CH2), 33.0 (CH2), 39.8 (CH2), 57.0 (CH-S), 
79.3 (CH-O), 125.1 (CH=), 125.3 (CH=), 127.1 (CH=), 127.9 (CH=), 140.1 (C), 140.6 (C). 
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(1S,2S)-1-(tert-Butylthio)-2,3-dihydro-1H-inden-2-ol (5). Yield: 320 mg (72%), pale 
orange solid. SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to 
cyclohexane/EtOAc = 80:20). 1H NMR (400 MHz, CDCl3): δ= 1.45 (s, 3H, CH3, 
tBu), 2.29 
(bs, 1H, OH), 2.86 (dd, 1H, CH2,
 2JH-H =15.8, 
3JH-H =5.6 Hz), 3.32 (dd, 1H, CH2,
 2JH-H =15.8, 
3JH-H =6.4 Hz), 4.03 (d, 1H, CH-S, 
3JH-H =5.3 Hz), 4.39-4.44 (m, 1H, CH-O), 7.19-7.25 (m, 
3H, CH=), 7.38 (m, 1H, CH=), 7.36 (m , 1H, CH=).13C NMR (100.6 MHz, CDCl3): δ= 31.7 
(CH3, 
tBu), 39.9 (CH2), 43.7 (C, 
tBu), 54.6 (CH-S), 80.8 (CH-O), 124.8 (CH=), 125.6 (CH=), 
127.2 (CH=), 127.7 (CH=), 139.7 (C), 142.0 (C).  
(1S,2S)-1-(Phenylthio)-2,3-dihydro-1H-inden-2-ol (6). Yield: 373 mg (77%), white 
solid. SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to 
cyclohexane/EtOAc = 80:20). 1H NMR (400 MHz, CDCl3): δ= 2.09 (bs, 1H, OH), 2.82 (dd, 
1H, CH2,
 2JH-H =16.3, 
3JH-H =3.5 Hz), 3.32 (dd, 1H, CH2,
 2JH-H =16.3, 
3JH-H =6.2 Hz), 4.50 (dt, 
1H, CH-O, 3JH-H =6.2 Hz, 
3JH-H =3.4 Hz), 4.55 (d, 1H, CH-S, 
3JH-H =3.3 Hz), 7.19-7.24 (m, 
4H, CH=), 7.26-7.31 (m, 2H, CH=), 7.34-7.37 (m, 1H, CH=), 7.40-7.43 (m, 2H, CH=).13C 
NMR (100.6 MHz, CDCl3): δ= 39.9 (CH2), 59.1 (CH-S), 79.6 (CH-O), 125.2 (CH=), 125.7 
(CH=), 126.9 (CH=), 127.2 (CH=), 128.3 (CH=), 129.0 (CH=), 130.9 (CH=), 135.2 (CH=), 
139.9 (CH=), 135.2 (C), 139.9 (C), 140.6 (C). 
(1S,2S)-1-((2,6-Dimethylphenyl)thio)-2,3-dihydro-1H-inden-2-ol (7). Yield: 427 mg 
(79%), white solid. SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to 
cyclohexane/EtOAc = 80:20). 1H NMR (400 MHz, CDCl3): δ= 1.75 (bs, 1H, OH), 2.47 (s, 
6H, CH3), 2.82 (dd, 1H, CH2,
 2JH-H =16.6, 
3JH-H =2.1 Hz), 3.52 (dd, 1H, CH2,
 2JH-H =16.6, 
3JH-
H =5.5 Hz), 4.32 (d, 1H, CH-S, 
3JH-H =2.0 Hz), 4.36 (tt, 1H, CH-O, 
3JH-H =5.5 Hz, 
3JH-H =2.1 
Hz), 6.94 (d, 1H, CH=, 3JH-H =7.5 Hz), 7.06-7.16 (m, 4H, CH=), 7.18-7.26 (m, 2H, CH=). 
13C 
NMR (100.6 MHz, CDCl3): δ= 21.9 (CH3), 40.3 (CH2), 58.8 (CH-S), 78.5 (CH-O), 125.3 
(CH=), 125.4 (CH=), 126.7 (CH=), 128.1 (CH=), 128.2 (CH=), 128.7 (CH=), 132.0 (CH=), 
140.4 (C), 140.7 (C), 143.6 (C). 
(1S,2S)-1-((4-(Trifluoromethyl)phenyl)thio)-2,3-dihydro-1H-inden-2-ol (8). Yield: 478 
mg (77%), yellow oil. SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to 
cyclohexane/EtOAc = 80:20). 1H NMR (400 MHz, CDCl3): δ= 2.06 (d, 1H, OH, 
3JH-H =4.9 
Hz), 2.91 (dd, 1H, CH2,
 2JH-H =16.5, 
3JH-H =3.5 Hz), 3.42 (dd, 1H, CH2,
 2JH-H =16.5, 
3JH-H =6.0 
Hz), 4.55 (m, 1H, CH-O), 4.69 (d, 1H, CH-S, 3JH-H =3.2 Hz), 7.21-7.30 (m, 3H, CH=), 7.36-
7.41 (m, 1H, CH=), 7.46-7.57 (m, 4H, CH=). 13C NMR (100.6 MHz, CDCl3): δ= 40.2 (CH2), 
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58.0 (CH-S), 78.6 (CH-O), 124.1 (CH=), 125.4 (CH=), 125.7 (CH=), 125.8 (q, CH=, 3JH-F 
=3.8 Hz), 127.4 (CH=), 128.2 (q, C, 2JH-F =32.8 Hz), 128.7 (CH=), 128.8 (CH=), 139.0 (C), 
140.6 (C), 141.3 (C). 
(1S,2S)-1-((4-Methoxyphenyl)thio)-2,3-dihydro-1H-inden-2-ol (9). Yield: 541 mg 
(79%), yellow oil. SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to 
cyclohexane/EtOAc = 75:25). 1H NMR (400 MHz, CDCl3): δ= 1.97 (d, 1H, OH, 
3JH-H =5.2 
Hz), 2.81 (dd, 1H, CH2,
 2JH-H =16.3, 
3JH-H =3.5 Hz), 3.25 (dd, 1H, CH2,
 2JH-H =16.3, 
3JH-H =6.1 
Hz), 3.79 (s, 3H, CH3O), 4.38 (d, 1H, CH-S, 
3JH-H =3.3 Hz), 4.50 (tt, 1H, CH-O, 
3JH-H =6.1 
Hz, 3JH-H =3.5 Hz), 6.82 (d, 2H, CH=, 
3JH-H =8.7 Hz), 7.19-7.27 (m, 3H, CH=), 7.35-7.42 (m, 
3H, CH=). 13C NMR (100.6 MHz, CDCl3): δ= 39.9 (CH2), 55.3 (CH-S), 60.6 (CH3O), 78.6 
(CH-O), 114.6 (CH=), 124.4 (CH=), 125.2 (CH=), 125.6 (CH=), 127.0 (CH=), 128.1 (CH=), 
135.1 (C), 140.2 (C), 140.6 (C), 159.6 (C). 
(1S,2S)-1-(Anthracen-9-ylthio)-2,3-dihydro-1H-inden-2-ol (12). Yield: 308 mg 
(45%), yellow solid. SiO2-chromatography (gradient from cyclohexane/EtOAc = 100:0 to 
cyclohexane/EtOAc = 80:20).. 1H NMR (400 MHz, CDCl3): δ= 1.33 (d, 1H, OH, 
3JH-H 
=5.1 Hz), 2.80 (dd, 1H, CH2,
 2JH-H =16.4, 
3JH-H =2.6 Hz), 3.58 (dd, 1H, CH2,
 2JH-H =16.4, 
3JH-H =5.6 Hz), 4.40 (m, 1H, CH-O), 4.55 (d, 1H, CH-S, 
3JH-H =2.2 Hz), 7.16 (t, 1H, 
CH=, 3JH-H =7.5 Hz), 7.24 (t, 1H, CH=, 
3JH-H =7.5 Hz), 7.25-7.30 (m , 2H, CH=), 7.52 
(ddd, 2H, CH=, 3JH-H =8.0 Hz, 
3JH-H =6.5 Hz, 
4JH-H =1.1 Hz), 7.61 (ddd, 2H, CH=,
 3JH-H 
=8.9 Hz, 3JH-H =6.5 Hz, 
4JH-H =1.0 Hz), 8.05 (d, 2H, CH=,
 3JH-H =8.4 Hz), 8.54 (s, 1H, 
CH=), 8.98 (dq, 2H, CH=, 3JH-H =8.9, 
4JH-H =1.0 Hz).
13C NMR (100.6 MHz, CDCl3): δ= 
40.1 (CH2), 61.2 (CH-S), 78.7 (CH-O), 125.3 (CH=), 125.4 (CH=), 125.7 (CH=), 126.6 
(CH=), 126.9 (CH=), 127.0 (CH=), 127.7 (CH=), 128.4 (CH=), 129.1 (CH=), 129.6 (C), 
131.8 (C), 134.9 (C), 140.2 (C), 140.8 (C). 
 
4.3. General procedure for the preparation of phosphite-thioether ligands L1-
L8a-c 
The corresponding phosphorochloridite (1.1 mmol) produced in situ was dissolved in toluene 
(5 mL), and pyridine (0.3 mL, 3.9 mmol) was added. The corresponding thioether-hydroxyl 
compound (1 mmol) was azeotropically dried with toluene (3 x 2 mL) and then dissolved in 
toluene (5 mL) to which pyridine (0.3 mL, 3.9 mmol) was added. The alcohol solution was 
transferred slowly to a solution of phosphorochloridite. The reaction mixture was stirred at 80 
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ºC for 90 min, after which the pyridine salts were removed by filtration. Evaporation of the 
solvent gave a white foam, which was purified by flash chromatography in silica 
(Hexane/Toluene/NEt3 = 7/3/1) to produce the corresponding ligand as a white solid. 
L1a. Yield: 320.8 mg (50%). 31P NMR (161.9 MHz, C6D6): δ=141.5 (s). 
1H NMR (400 
MHz, C6D6): δ=1.09 (d, 3H, CH3, 
iPr, 3JH-H =6.4 Hz), 1.07 (d, 3H, CH3, 
iPr, 3JH-H =6.8 Hz), 
1.26 (s, 9H, CH3, 
tBu), 1.28 (s, 9H, CH3, 
tBu), 1.54 (s, 9H, CH3, 
tBu), 1.56 (s, 9H, CH3, 
tBu), 
2.90-2.96 (m, 2H, CH2, CH 
iPr), 3.23 (dd, 1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =5.6 Hz), 4.57 (b, 
1H, CH-S), 5.18 (m, 1H, CH-OP), 6.94-7.12 (m, 3H, CH=), 7.31 (s, 1H, CH=), 7.33 (d, 1H, 
CH=, 4JH-H =2.8 Hz), 7.34 (d, 1H, CH=,
 4JH-H =2.4 Hz), 7.57 (d, 1H, CH=, 
4JH-H =2.4 Hz), 
7.59 (d, 1H, CH=, 4JH-H =2.4 Hz), 
13C NMR (100.6 MHz, C6D6): δ=23.4 (CH3, 
iPr), 23.8 
(CH3, 
iPr), 31.0 (d, CH3, 
tBu, JC-P =7.6 Hz), 31.1 (CH3, 
tBu), 34.2 (C, tBu), 34.9 (C, tBu), 35.3 
(CH, iPr), 39.1 (CH2), 54.7 (CH-S), 82.8 (CH-OP), 124.1-146.6 (aromatic carbons). MS HR-
ESI [found 669.3498, C40H55O3PS (M-Na)
+ requires 669.3502]. 
L1b. Yield: 220.8 mg (37%). 31P NMR (161.9 MHz, C6D6): δ=130.2 (s). 
1H NMR (400 
MHz, C6D6): δ=1.03 (d, 3H, CH3, 
iPr, 3JH-H =6.8 Hz), 1.23 (d, 3H, CH3, 
iPr, 3JH-H =6.4 Hz), 
1.49 (s, 9H, CH3, 
tBu), 1.53 (s, 9H, CH3, 
tBu), 1.64 (s, 3H, CH3), 1.76 (s, 3H, CH3), 2.01 (s, 
3H, CH3), 2.07 (s, 3H, CH3), 2.71-2.77 (m, 1H, CH, 
iPr), 2.88 (d, 1H, CH2, 
2JH-H =16.4 Hz), 
3.27 (dd, 1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =4.8 Hz), 4.81 (b, 1H, CH-S), 4.92 (m, 1H, CH-OP), 
6.89-7.12 (m, 3H, CH=), 7.19 (m, 2H, CH=), 7.35 (d, 1H, CH=, 3JH-H =8.8 Hz). 
13C NMR 
(100.6 MHz, C6D6): δ=16.3 (CH3), 16.6 (CH3), 20.0 (CH3), 20.1 (CH3), 23.3 (CH3, 
iPr), 24.2 
(CH3, 
iPr), 31.3 (CH3, 
tBu),  31.4 (d, CH3, 
tBu, JC-P =5.3 Hz), 34.6 (C, 
tBu), 34.7 (C, tBu), 34.8 
(CH, iPr), 39.3 (CH2), 55.0 (CH-S), 82.9 (CH-OP), 124.9-146.4 (aromatic carbons). MS HR-
ESI [found 613.2903, C36H47O3PS (M-Na)
+ requires 613.2876].    
L1c. Yield: 202.0 mg (34%). 31P NMR (161.9 MHz, C6D6): δ=139.4 (s). 
1H NMR (400 
MHz, C6D6): δ=1.09 (d, 3H, CH3, 
iPr, 3JH-H =6.8 Hz), 1.12 (d, 3H, CH3, 
iPr, 3JH-H =6.8 Hz), 
1.47 (s, 9H, CH3, 
tBu), 1.61 (s, 9H, CH3, 
tBu), 1.69 (s, 3H, CH3), 1.75 (s, 3H, CH3), 2.05 (s, 
6H, CH3), 2.85-2.91 (m, 1H, CH, 
iPr), 3.37 (d, 1H, CH2, 
2JH-H =16.4 Hz), 3.38 (dd, 1H, CH2, 
2JH-H =16.8 Hz, 
3JH-H =6.0 Hz), 4.24 (d, 1H, CH-S, 
3JH-H =4.8 Hz), 5.07-5.11 (m, 1H, CH-OP), 
6.95-7.03 (m, 3H, CH=), 7.18 (s, 1H, CH=), 7.23 (2H, CH=). 13C NMR (100.6 MHz, C6D6): 
δ=16.3 (CH3, 
iPr), 16.5 (CH3, 
iPr), 20.1 (CH3), 23.5 (CH3), 23.9 (CH3), 31.3 (CH3, 
tBu),  31.4 
(d, CH3, 
tBu, JC-P =5.3 Hz), 34.6 (C, 
tBu), 34.8 (CH, iPr), 39.7 (CH2), 54.7 (CH-S), 82.7 (d, 
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CH-OP, 2JC-P =6.1 Hz), 124.9-145.5 (aromatic carbons). MS HR-ESI [found 
613.2869, C36H47O3PS (M-Na)
+ requires 613.2876].          
L2b. Yield: 352.2 mg (59%). 31P NMR (161.9 MHz, C6D6): δ=132.4 (s). 
1H NMR (400 
MHz, C6D6): δ=0.82 (pt, 3H, CH3, Pr, 
3JH-H =7.2 Hz), 1.41-1.53 (m, 2H, CH2, Pr), 1.53 (s, 9H, 
CH3, 
tBu), 1.58 (s, 9H, CH3, 
tBu), 1.69 (s, 3H, CH3), 1.80 (s, 3H, CH3), 2.05 (s, 3H, CH3), 
2.09 (s, 3H, CH3), 2.23-2.30 (m, 1H, CH2, Pr), 2.44-2.50 (m, 2H, CH2, Pr), 2.93 (d, 1H, CH2, 
2JH-H =16.8 Hz), 3.25 (dd, 1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =5.2 Hz), 4.72 (b, 1H, CH-S), 4.90-
4.94 (m, 1H, CH-OP), 6.92 (d, 1H, CH=, 3JH-H =6.4 Hz), 7.00-7.03 (m, 2H, CH=), 7.22 (d, 
2H, CH=, 3JH-H =8.0 Hz), 7.37 (d, 2H, CH=, 
3JH-H =6.8 Hz). 
13C NMR (100.6 MHz, C6D6): 
δ=13.2 (CH3, Pr), 16.2 (CH3), 16.5 (CH3), 20.0 (CH3), 20.1 (CH3), 23.0 (CH2, Pr), 31.3 (CH3, 
tBu, JC-P =5.3 Hz), 31.4 (CH3, 
tBu), 33.1 (CH2, Pr), 34.6 (C, 
tBu), 34.7 (C, tBu), 39.2 (d, CH2, 
3JC-P =3.8 Hz), 56.1 (d, CH-S, 
3JC-P =3.0 Hz), 82.4 (CH-OP), 124.8-146.1 (aromatic carbons). 
MS HR-ESI [found 613.2903, C36H47O3PS (M-Na)
+ requires 613.2876].                
L3b. Yield: 283.6 mg (47%). 31P NMR (161.9 MHz, C6D6): δ=134.2 (s). 
1H NMR (400 
MHz, C6D6): δ=1.34 (s, 9H, CH3, 
tBu), 1.48 (s, 9H, CH3, 
tBu), 1.58 (s, 9H, CH3, 
tBu), 1.69 (s, 
3H, CH3), 1.74 (s, 3H, CH3), 2.05 (s, 3H, CH3), 2.06 (s, 3H, CH3), 2.71 (d, 1H, CH2, 
2JH-H 
=16.0 Hz), 3.12 (dd, 1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =5.2 Hz), 4.56 (b, 1H, CH-S), 5.22-5.25 
(m, 1H, CH-OP), 6.83 (d, 1H, CH=, 3JH-H =7.2 Hz), 6.96-7.21 (m, 1H, CH=), 7.41 (d, 1H, 
CH=, 3JH-H =7.6 Hz). 
13C NMR (100.6 MHz, C6D6): δ=16.3 (CH3), 16.5 (CH3), 20.0 (CH3), 
20.1 (CH3), 31.4 (CH3, 
tBu), 34.6 (C, tBu), 34.7 (C, tBu), 38.8 (CH2), 43.5 (C, 
tBu), 54.0 (d, 
CH-S, 3JC-P =3.8 Hz), 83.7 (CH-OP), 124.7-145.7 (aromatic carbons). MS HR-ESI [found 
627.3026, C37H49O3PS (M-Na)
+ requires 627.3032].              
L4b. Yield: 284.8 mg (41%). 31P NMR (161.9 MHz, C6D6): δ=135.3 (s). 
1H NMR (400 
MHz, C6D6): δ=1.44 (s, 9H, CH3, 
tBu), 1.51 (s, 9H, CH3, 
tBu), 1.69 (s, 3H, CH3), 1.77 (s, 3H, 
CH3), 2.06 (s, 3H, CH3), 2.07 (s, 3H, CH3), 2.73 (d, 1H, CH2, 
2JH-H =16.8 Hz), 2.93 (dd, 1H, 
CH2, 
2JH-H =17.2 Hz, 
3JH-H =5.6 Hz), 4.95 (b, 1H, CH-S), 5.03-5.06 (m, 1H, CH-OP), 6.80-
6.82 (m, 1H, CH=), 6.90-7.01 (m, 5H, CH=), 7.21 (d, 2H, CH=, 3JH-H =3.6 Hz), 7.27-7,29 (m, 
3H, CH=). 13C NMR (100.6 MHz, C6D6): δ=16.2 (CH3), 16.5 (CH3), 20.0 (CH3), 20.1 (CH3), 
31.3 (CH3, 
tBu), 31.4 (CH3, 
tBu), 34.5 (C, tBu), 34.6 (C, tBu), 39.2 (d, CH2, 
3JC-P =3.0 Hz), 
58.8 (d, CH-S, 3JC-P =3.8 Hz), 81.6 (d, CH-OP, 
2JC-P =4.6 Hz), 124.8-145.7 (aromatic 
carbons). MS HR-ESI [found 647.2737, C39H45O3PS (M-Na)
+ requires 647.2719].                      
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L5b. Yield: 324.6 mg (42%). 31P NMR (161.9 MHz, C6D6): δ=135.7 (s). 
1H NMR (400 
MHz, C6D6): δ=1.42 (s, 9H, CH3, 
tBu), 1.52 (s, 9H, CH3, 
tBu), 1.68 (s, 3H, CH3), 1.79 (s, 3H, 
CH3), 2.04 (s, 3H, CH3), 2.08 (s, 3H, CH3), 2.31 (s, 6H, CH3), 2.90 (d, 1H, CH2, 
2JH-H =16.8 
Hz), 3.38 (dd, 1H, CH2, 
2JH-H =16.8 Hz, 
3JH-H =4.8 Hz), 4.80-4.83 (m, 1H, CH-OP), 4.91 (s, 
1H, CH-S), 6.67 (d, 1H, CH=, 3JH-H =7.2 Hz), 6.83 (pt, 1H, CH=, 
3JH-H =7.2 Hz), 6.88-7.03 
(m, 5H, CH=), 719 (d, 1H, CH=, 4JH-H =2.4 Hz). 
13C NMR (100.6 MHz, C6D6): δ=16.2 (CH3), 
16.5 (CH3), 20.0 (CH3), 20.1 (CH3), 21.7 (CH3), 31.2 (CH3, 
tBu),  31.3 (d, CH3, 
tBu, JC-P =5.4 
Hz), 34.5 (C, tBu), 34.6 (C, tBu), 39.3 (d, CH2, 
3JC-P =3.8 Hz), 58.0 (d, CH-S, 
3JC-P =3.8 Hz), 
81.3 (d, CH-OP, 2JC-P =4.6 Hz), 124.8-145.6 (aromatic carbons). MS HR-ESI [found 
675.3026, C41H49O3PS (M-Na)
+ requires 675.3032].              
L5c. Yield: 276.4 mg (36%). 31P NMR (161.9 MHz, C6D6): δ=137.5 (s). 
1H NMR (400 
MHz, C6D6): δ=1.44 (s, 9H, CH3, 
tBu), 1.56 (s, 9H, CH3, 
tBu), 1.69 (s, 3H, CH3), 1.74 (s, 3H, 
CH3), 2.05 (s, 3H, CH3), 2.06 (s, 3H, CH3), 2.25 (s, 6H, CH3), 3.19 (d, 1H, CH2, 
2JH-H =16.8 
Hz), 3.50 (dd, 1H, CH2, 
2JH-H =17.2 Hz, 
3JH-H =4.8 Hz), 4.60 (b, 1H, CH-S), 4.93 (m, 1H, CH-
OP), 6.46 (d, 1H, CH=, 3JH-H =7.2 Hz), 6.79 (m, 1H, CH=), 6.86-7.22 (m, 6H, CH=), 7.22 (s, 
1H, CH=). 13C NMR (100.6 MHz, C6D6): δ=16.2 (CH3), 16.4 (CH3), 20.0 (CH3), 20.7 (CH3), 
31.3 (CH3, 
tBu), 34.5 (C, tBu), 34.6 (C, tBu), 40.2 (d, CH2, 
3JC-P =3.0 Hz), 57.5 (d, CH-S, 
3JC-P 
=3.8 Hz), 81.0 (d, CH-OP, 3JC-P =7.6 Hz), 124.8-145.5 (aromatic carbons). MS HR-ESI 
[found 675.3041, C41H49O3PS (M-Na)
+ requires 675.3032].      
L6b. Yield: 336.1 mg (52%). 31P NMR (161.9 MHz, C6D6): δ=135.6 (s). 
1H NMR (400 
MHz, C6D6): δ=1.41 (s, 9H, CH3, 
tBu), 1.47 (s, 9H, CH3, 
tBu), 1.69 (s, 3H, CH3), 1.74 (s, 3H, 
CH3), 2.05 (s, 3H, CH3), 2.06 (s, 3H, CH3), 2.67 (d, 1H, CH2, 
2JH-H =16.8 Hz), 2.99 (dd, 1H, 
CH2, 
2JH-H =16.8 Hz, 
3JH-H =6.0 Hz), 4.92 (b, 1H, CH-S), 4.96-5.01 (m, 1H, CH-OP), 6.82-
6.84 (m, 1H, CH=), 6.99-7.19 (m, 8H, CH=), 7.24-7.26 (m, 1H, CH=). 13C NMR (100.6 MHz, 
C6D6): δ=16.9 (CH3), 17.1 (CH3), 20.6 (CH3), 20.7 (CH3), 31.9 (d, CH3, 
tBu,  3JC-P =5.3 Hz), 
32.0 (CH3,
tBu), 35.2 (C,tBu), 35.3 (C,tBu), 39.6 (CH2), 58.3 (d, CH-S, 
3JC-P =3.8 Hz), 81.7 (d, 
CH-OP, 3JC-P =4.6 Hz), 125.7-146.2 (aromatic carbons). MS HR-ESI [found 
715.2610, C40H44F3O3PS (M-Na)
+ requires 715.2593].          
L7b. Yield: 321 mg (49%). 31P NMR (161.9 MHz, C6D6): δ=135.4 (s). 
1H NMR (400 
MHz, C6D6): δ=1.47 (s, 9H, CH3, 
tBu), 1.55 (s, 9H, CH3, 
tBu), 1.71 (s, 3H, CH3), 1.82 (s, 3H, 
CH3), 2.07 (s, 3H, CH3), 2.10 (s, 3H, CH3), 2.78 (d, 1H, CH2, 
2JH-H =16.8 Hz), 2.87 (dd, 1H, 
CH2, 
2JH-H =16.8 Hz, 
3JH-H =5.6 Hz), 3.16 (s, CH3, p-OMe) 4.88 (b, 1H, CH-S), 5.04-5.07 (m, 
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1H, CH-OP), 6.54 (d, 2H, CH=, 3JH-H =8.8 Hz), 6.82 (d, 1H, CH=, 
3JH-H =6.8 Hz), 6.96-7.23 
(m, 6H, CH=), 7.31 (d, 1H, CH=, 3JH-H =7.2 Hz). 
13C NMR (100.6 MHz, C6D6): δ=16.7 
(CH3), 16.9 (CH3), 20.4 (CH3), 20.5 (CH3), 31.7 (CH3, 
tBu), 31.8 (CH3,
tBu), 35.0 (C,tBu), 
35.1 (C,tBu), 39.9 (CH2), 54.8 (CH3, p-MeO), 60.5 (d, CH-S, 
3JC-P =3.8 Hz), 82.4 (d, CH-OP, 
3JC-P =4.6 Hz), 114.7-160.4 (aromatic carbons). MS HR-ESI [found 677.2851, C40H47O4PS 
(M-Na)+ requires 677.2825].     
L8b. Yield: 94.3 mg (27%). 31P NMR (161.9 MHz, C6D6): δ=136.1 (s). 
1H NMR (400 
MHz, C6D6): δ=1.28 (s, 9H, CH3, 
tBu), 1.39 (s, 9H, CH3, 
tBu), 1.65 (s, 3H, CH3), 1.79 (s, 3H, 
CH3), 2.02 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.91 (d, 1H, CH2, 
2JH-H =16.8 Hz), 3.45 (dd, 1H, 
CH2, 
2JH-H =16.8 Hz, 
3JH-H =5.2 Hz), 4.92-4.95 (m, 1H, CH-OP), 5.22 (b, 1H, CH-S), 6.55-
6.63 (m, 2H, CH=), 6.90 (s, 2H, CH=), 7.11-7.28 (m, 6H, CH=), 7.73 (d, 2 H, CH=, 3JH-H =8,0 
Hz), 8.16 (s, 1, CH=), 8.96 (d, 2 H, CH=, 3JH-H =8,4 Hz). 
13C NMR (100.6 MHz, C6D6): 
δ=16.2 (CH3), 16.6 (CH3), 20.0 (CH3), 20.1 (CH3), 31.1 (CH3, 
tBu), 31.3 (d, CH3, 
tBu, JC-P 
=5.4 Hz), 34.4 (C, tBu), 39.7 (CH2), 60.1 (CH-S), 81.4 (CH-OP), 124.8-145.7 (aromatic 
carbons). MS HR-ESI [found 747.3048, C47H49O3PS (M-Na)
+ requires 747.3028].     
L8c. Yield: 102 mg (29%). 31P NMR (161.9 MHz, C6D6): δ=134.7 (s). 
1H NMR (400 
MHz, C6D6): δ=1.33 (s, 9H, CH3, 
tBu), 1.45 (s, 9H, CH3, 
tBu), 1.66 (s, 3H, CH3), 1.84 (s, 3H, 
CH3), 2.01 (s, 3H, CH3), 2.07 (s, 3H, CH3), 2.94 (d, 1H, CH2, 
2JH-H =16.2 Hz), 3.54 (dd, 1H, 
CH2, 
2JH-H =16.2 Hz, 
3JH-H =6.2 Hz), 5.02 (m, 1H, CH-OP), 5.27 (b, 1H, CH-S), 6.64 (m, 2H, 
CH=), 6.95 (s, 2H, CH=), 7.11-7.27 (m, 6H, CH=), 7.72 (d, 2 H, CH=, 3JH-H =7.6 Hz), 8.04 (s, 
1, CH=), 8.92 (d, 2 H, CH=, 3JH-H =8.0 Hz). 
13C NMR (100.6 MHz, C6D6): δ=16.4 (CH3), 
16.5 (CH3), 20.2 (CH3), 20.7 (CH3), 31.4 (CH3, 
tBu), 31.7 (CH3, 
tBu), 34.6 (C, tBu), 34.8 (C, 
tBu), 40.1 (CH2), 58.4 (CH-S), 81.4 (CH-OP), 125.2-146.9 (aromatic carbons). MS HR-ESI 
[found 747.3032, C47H49O3PS (M-Na)
+ requires 747.3028].   
 
4.4. General procedure for the preparation of phosphinite-thioether ligands L1-
L8d-g 
The corresponding thioether-hydroxyl compound (0.5 mmol) and DMAP (6.7 mg, 0.055 
mmol) were dissolved in toluene (1 ml), and triethylamine was added (0.09 ml, 0.65 mmol) at 
rt, followed by the addition of the corresponding chlorophosphine (0.55 mmol) via syringe. 
The reaction was stirred for 20 min at room temperature. The solvent was removed in vacuo, 
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and the product was purified by flash chromatography on alumina (toluene/NEt3 = 100/1) to 
produce the corresponding ligand as an oil.  
L1e. Yield: 257.8 mg (61%). 31P NMR (161.9 MHz, C6D6): δ=98.2 (s). 
1H NMR (400 
MHz, C6D6): δ=1.08 (d, 3H, CH3, 
iPr, 3JH-H =6.8 Hz), 1.21 (d, 3H, CH3, 
iPr, 3JH-H =6.4 Hz), 
2.37 (s, 3H,  CH3, o-Tol), 2.41 (s, 3H,  CH3, o-Tol), 2.91-3.01 (m, 2H, CH 
iPr, CH2), 3.30 (dd, 
1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =6.0 Hz), 4.49 (b, 1H, CH-S), 4.82 (m, 1H, CH-OP), 6.91-7.15 
(m, 9H, CH=), 7.36 (d, 1H, CH=, 3JH-H =6.8 Hz), 7.52 (m, 2H, CH=). 
13C NMR (100.6 MHz, 
C6D6): δ=20.3 (d,CH3, o-Tol, 
3JC-P =4.0 Hz), 20.5 (d,CH3, o-Tol, 
3JC-P =4.4 Hz),  23.2 (CH3, 
iPr), 23.8 (CH3, 
iPr), 35.3 (CH, iPr), 39.1 (d, CH2, 
3JC-P =6.1 Hz), 54.7 (d, CH-S, 
3JC-P =6.1 
Hz), 87.7 (d, CH-OP, 2JC-P =20,7 Hz), 124.8-141.4 (aromatic carbons). 
L1f. Yield: 128.9 mg (61%). 31P NMR (161.9 MHz, C6D6): δ=140.4 (s). 
1H NMR (400 
MHz, C6D6): δ=1.08-1.20 (m, 6H, CH2, Cy), 1.22 (d, 3H, CH3, 
iPr, 3JH-H =6.4 Hz), 1.25-1.35 
(m, 5H, CH2, Cy), 1.38 (d, 3H, CH3, 
iPr, 3JH-H =6.4 Hz), 1.48-1.61 (m, 5H, CH2, Cy), 1.69 (b, 
5H, CH, CH2, Cy), 1.86 (m, 2H, CH2, Cy), 2.98 (d, 1H, CH2, 
2JH-H =16.0 Hz), 3.10-3.17 (m, 
1H, CH iPr), 3.41 (dd, 1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =5.6 Hz), 4.51-4.54 (m, 2H, CH-S, CH-
OP), 6.99-7.15 (m, 3H, CH=), 7.40 (d, 1H, CH=, 3JH-H =8.0 Hz), 7.52 (m, 2H, CH=). 
13C 
NMR (100.6 MHz, C6D6): δ=23.3 (CH3, 
iPr), 24.0 (CH3, 
iPr), 26.5-27.1 (CH2, Cy), 28.1 (CH2, 
Cy), 28.3 (CH2, Cy), 28.5 (CH2, Cy), 35.2 (CH, 
iPr), 37.6 (d, CH, 1JC-P =8.5 Hz), 37.8 (d, CH, 
1JC-P =9.9 Hz), 39.3 (d, CH2, 
3JC-P =6.1 Hz), 54.8 (d, CH-S, 
3JC-P =6.1 Hz), 87.7 (d, CH-OP, 
2JC-P =18.4 Hz), 124.8-141.5 (aromatic carbons).  
L1g. Yield: 129.9 mg (54%). 31P NMR (161.9 MHz, C6D6): δ=114.5 (s). 
1H NMR (400 
MHz, C6D6): δ=1.11 (d, 3H, CH3, 
iPr, 3JH-H =6.8 Hz), 1.22 (d, 3H, CH3, 
iPr, 3JH-H =6.4 Hz), 
2.04 (s, 3H,  p-CH3, Mes), 2.06 (s, 3H,  p-CH3, Mes), 2.39 (s, 12H, o-CH3, Mes), 2.85-2.99 
(m, 2H, CH iPr, CH2), 3.33 (dd, 1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =5.6 Hz), 4.46 (b, 1H, CH-S), 
4.66 (m, 1H, CH-OP), 6.63 (s, 1H, CH=), 6.64 (s, 1H, CH=), 6.65 (s, 1H, CH=), 6.66 (s, 1H, 
CH=), 6.94-7.05 (m, 2H, CH=), 7.12 (m, 1H, CH=), 7.31 (m, 1H, CH=). 13C NMR (100.6 
MHz, C6D6): δ=20.6 (p-CH3, Mes), 22.1 (d, o-CH3, Mes, 
3JC-P =3.0 Hz), 22.2 (d, o-CH3, Mes, 
3JC-P =3.1 Hz), 23.2 (CH3, 
iPr), 23.9 (CH3, 
iPr), 35.2 (CH, iPr), 38.9 (d, CH2, 
3JC-P =6.8 Hz), 
54.6 (d, CH-S, 3JC-P =7.6 Hz), 87.6 (d, CH-OP, 
2JC-P =22,1 Hz), 124.7-141.6 (aromatic 
carbons).  
L3e. Yield: 147,6 mg (31%). 31P NMR (161.9 MHz, C6D6): δ=97.7 (s). 
1H NMR (400 
MHz, C6D6): δ=1.24 (s, 9H, CH3, 
tBu), 2.32 (s, 3H, CH3, o-Tol), 2.41 (s, 3H, CH3, o-Tol), 
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2.92 (dd, 1H, CH2, 
2JH-H =16.4 Hz, 
3JH-H =2.8 Hz), 3.22 (dd, 1H, CH2, 
2JH-H =16.0 Hz, 
3JH-H 
=5.2 Hz), 4.40 (b, 1H, CH-S), 4.82-4.85 (m, 1H, CH-OP),  6.89-7.12 (m, 9H, CH=), 7.39 (d, 
1H, CH=, 3JH-H =7.2 Hz), 7.50-7.54 (m, 2H, CH=). 
13C NMR (100.6 MHz, C6D6): δ=20.2 (d, 
CH3, 
3JC-P =15.3 Hz), 20.4 (d, CH3, 
3JC-P =16.0 Hz), 31.3 (CH3, 
tBu), 39.0 (d, CH2, 
3JC-P =6.0 
Hz), 43.4 (C, tBu), 53.6 (d, CH-S, 3JC-P =6.8 Hz), 88.5 (d, CH-OP, 
3JC-P =20.6 Hz), 124.6-
142.3 (aromatic carbons). MS HR-ESI [found 457.1731, C27H31OPS (M-Na)
+ requires 
457.1725].   
L5e. Yield: 260.6 mg (54%). 31P NMR (161.9 MHz, C6D6): δ=98.5 (s). 
1H NMR (400 
MHz, C6D6): δ=2.30 (s, 3H, CH3, o-Tol), 2.35 (s, 3H, CH3, o-Tol), 2.44 (s, 6H, CH3), 3.14 (d, 
1H, CH2, 
2JH-H =16.8 Hz), 3.54 (dd, 1H, CH2, 
2JH-H =16.8 Hz, 
3JH-H =5.2 Hz), 4.78-4.82 (m, 
1H, CH-OP),  4.83 (b, 1H, CH-S), 6.91-7.14 (m, 12H, CH=), 7.23 (s, 1H, CH=), 7.32-7.35 
(m, 1H, CH=), 7.40-7.44 (m, 1H, CH=). 13C NMR (100.6 MHz, C6D6): δ=20.1 (d, CH3, 
3JC-P 
=6.1 Hz), 20.3 (d, CH3, 
3JC-P =6.8 Hz), 21.7 (CH3), 39.4 (d, CH2, 
3JC-P =6.9 Hz), 58.0 (d, CH-
S, 3JC-P =6.9 Hz), 85.7 (d, CH-OP, 
3JC-P =5.4 Hz), 124.9-143.5 (aromatic carbons). 
 
4.5. Typical procedure for the allylic alkylation of disubstituted linear (S1 and 
S3-S7) and cyclic (S2 and S8-S9) substrates 
A degassed solution of [PdCl(3-C3H5)]2 (0.9 mg, 0.0025 mmol) and the corresponding 
ligand (0.0055 mmol) in dichloromethane (0.5 mL) was stirred for 30 min. Subsequently, a 
solution of the corresponding substrate (0.5 mmol) in dichloromethane (1.5 mL), nucleophile 
(1.5 mmol), N,O-bis(trimethylsilyl)-acetamide (370 L, 1.5 mmol) and a pinch of KOAc were 
added. The reaction mixture was stirred at room temperature. After the desired reaction time 
the reaction mixture was diluted with Et2O (5 mL) and saturated NH4Cl (aq) (25 mL) was 
added. The mixture was extracted with Et2O (3 x 10 mL) and the extract dried over MgSO4. 
Conversions were measured by 1H NMR and enantiomeric excesses were determined either 
by HPLC (compounds 11, 13-22, 37-41 and 43-46) or by GC (compounds 12, 47-48 and 50-
52) or by 1H NMR using [Eu(hfc)3] (compounds 42 and 49). For characterization and ee 
determination details see Supporting Information. 
 
4.6. Typical procedure for the allylic alkylation of disubstituted linear substrate 
S1 using pyrroles 
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A degassed solution of [PdCl(η3-C3H5)]2 (1.8 mg, 0.005 mmol) and the corresponding 
phosphite/phosphinite-thioether (0.011 mmol) in dichloromethane (0.5 mL) was stirred for 30 
min. Subsequently, a solution of the corresponding substrate (0.5 mmol) in dichloromethane 
(1.5 mL), the corresponding pyrrole (0.4 mmol) and K2CO3 (110 mg, 0.8 mmol) were added. 
The reaction mixture was stirred at room temperature. After 18 h, the reaction mixture was 
diluted with Et2O (5 mL) and saturated NH4Cl (aq) (25 mL) was added. The mixture was 
extracted with Et2O (3 x 10 mL) and the extract dried over MgSO4. Conversions were 
measured by 1H NMR and enantiomeric excesses were determined by HPLC. For 
characterization and ee determination details see Supporting Information. 
 
4.7. Typical procedure for the allylic amination of disubstituted linear substrate 
S1 
A degassed solution of [PdCl(3-C3H5)]2 (0.9 mg, 0.0025 mmol) and the corresponding 
ligand (0.0055 mmol) in dichloromethane (0.5 mL) was stirred for 30 min. Subsequently, a 
solution of rac-1,3-diphenyl-3-acetoxyprop-1-ene (S1) (0.5 mmol) in dichloromethane (1.5 
mL), the corresponding amine (1.5 mmol), N,O-bis(trimethylsilyl)-acetamide (370 L, 1.5 
mmol) and a pinch of KOAc were added. The reaction mixture was stirred at room 
temperature. After 2 hours, the reaction mixture was diluted with Et2O (5 mL) and saturated 
NH4Cl (aq) (25 mL) was added. The mixture was extracted with Et2O (3 x 10 mL) and the 
extract dried over MgSO4. Conversions were measured by 
1H NMR and enantiomeric 
excesses were determined by HPLC. For characterization and ee determination details see 
Supporting Information. 
 
4.8. Typical procedure for the allylic etherification and silylation of 
disubstituted linear substrate S1 
A degassed solution of [PdCl(3-C3H5)]2 (0.9 mg, 0.0025 mmol) and the corresponding 
ligand (0.0055 mmol) in dichloromethane (0.5 mL) was stirred for 30 min. Subsequently, a 
solution of rac-1,3-diphenyl-3-acetoxyprop-1-ene (S1) (31.5 mg, 0.125 mmol) in 
dichloromethane (1.5 mL) was added. After 10 minutes, Cs2CO3 (122 mg, 0.375 mmol) and 
the corresponding alcohol or silanol (0.375 mmol) were added. The reaction mixture was 
stirred at room temperature. After 18 h, the reaction mixture was diluted with Et2O (5 mL) 
and saturated NH4Cl (aq) (25 mL) was added. The mixture was extracted with Et2O (3 x 10 
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mL) and the extract dried over MgSO4. Conversions were measured by 
1H NMR and 
enantiomeric excesses were determined by HPLC. For characterization and ee determination 
details see Supporting Information. 
 
4.9. Typical procedure for the preparation of chiral carbo- and heterocyclic 
compounds 53-58 
A solution of Grubbs II catalyst (5 mg, 0.006 mmol) and the corresponding alkylated 
product (0.12 mmol) in CH2Cl2 (3 mL) was stirred for 16 h. The solution was directly purified 
by flash chromatography (Hex/EtOAc 95:5) to obtained the desired compounds. For 
characterization and ee determination details see Supporting Information. 
 
4.10. Typical procedure for the preparation of chiral tricyclic compounds 59-61  
A solution of the starting enyne (0.187 mmol) in 1 mL of tert-butylbenzene was added to a 
solution of Co2(CO)8 (83 mg, 0.243 mmmol) in 0.5 mL of tert-butylbenzene under air. The 
flask was rinsed with 0.5 mL more of the same solvent. The resulting mixture was stirred at 
room temperature for 1 h, until full consumption of the starting material was observed by 
TLC. After that, the system was heated at 170 C for a further hour. Then, it was cooled to 
room temperature, filtered on Celite with CH2Cl2 and concentrated in vacuo. The crude 
mixture was purified by flash column chromatography on silica gel eluting with 
cyclohexane/EtOAc (gradient form 90:10 to 70:30) to furnish the desired tricyclic compound 
as a white solid. For characterization and ee determination details see Supporting Information. 
 
4.11. General procedure for the preparation of [Pd(3-allyl)(L)]BF4 complexes 
62-65 
The corresponding ligand (0.05 mmol) and the complex [Pd(-Cl)(3-1,3-allyl)]2 (0.025 
mmol) were dissolved in CD2Cl2 (1.5 mL) at room temperature under argon. AgBF4 (9.8 mg, 
0.05 mmol) was added after 30 minutes and the mixture was stirred for 30 minutes. The 
mixture was then filtered over celite under argon and the resulting solutions were analyzed by 
NMR. After the NMR analysis, the complexes were precipitated as pale yellow solids by 
adding hexane.  
[Pd(3-1,3-cyclohexenylallyl)(L5b)]BF4 (62). 31P NMR (CD2Cl2, 298 K), : 106.7 (s, 1P). 




tBu), 1.42-1.56 (m, 2H, CH2, allyl), 1.52 (s, 9H, CH3, 
tBu), 1.62-1.71 (m, 2H, CH2, 
allyl), 1.81 (s, 3H, CH3), 1.97 (s, 3H, CH3), 2.23 (s, 3H, CH3), 2.41 (s, 3H, CH3), 2.68 (s, 3H, 
CH3, SR group), 2.91 (s, 3H, CH3, SR group), 3.23 (dd, 1H, CH2, 
2JH-H= 12.4 Hz, 
3JH-H= 7.2 
Hz), 3.51 (dd, 1H, CH2, 
2JH-H= 12.4 Hz, 
3JH-H= 6.4 Hz), 4.00 (m, 1H, CH allyl trans to S), 
4.81 (m, 1H, CH-O), 5.15 (d, 1H, CH-S, 3JH-H= 6.8 Hz), 5.24 (m, 1H, CH allyl central), 5.46 
(m, 1H, CH allyl trans to P), 6.71 (d, 1H, CH=, 3JH-H= 6 Hz), 7.18 (m, 1H, CH=), 7.3-7.5 (m, 
7H, CH=). 13C NMR (CD2Cl2, 298 K), : 18.1 (CH3), 18.2 (CH3), 20.9 (CH2 allyl), 21.9 
(CH3), 22.0 (CH3), 24.5 (CH3, SR group), 25.7 (CH3, SR group), 28.6 (CH2 allyl), 29.6 (CH2 
allyl), 32.9 (CH3, 
tBu), 33.5 (CH3, 
tBu), 36.6 (C, tBu), 36.9 (C, tBu), 39.4 (d, CH2, JC-P= 6 
Hz), 55.2 (CH-S), 83.6 (d, CH-O, JC-P= 4.8 Hz), 84.3 (d, CH allyl trans to S, JC-P= 6.5 Hz), 
100.6 (d, CH allyl trans to P, JC-P= 30.5 Hz), 115.0 (d, CH allyl central, JC-P= 8.7 Hz), 125.5-
147.3 (aromatic carbons). MS HR-ESI [found 839.2869, C47H58O3PPdS (M-BF4)
+ requires 
839.2874]. 
[Pd(3-1,3-cyclohexenylallyl)(L5c)]BF4 (63). 31P NMR (CD2Cl2, 298 K), : 106.2 (s, 1P). 
1H NMR(CD2Cl2, 298 K), : 1.18 (m, 1H, CH2, allyl), 1.47 (s, 9H, CH3, 
tBu), 1.55 (s, 9H, 
CH3, 
tBu), 1.51-1.72 (m, 3H, CH2, allyl), 1.84 (s, 3H, CH3), 1.86 (m, 1H, CH2, allyl), 2.14 (s, 
3H, CH3), 2.14 (m, 1H, CH2), 2.38 (s, 3H, CH3), 2.44 (s, 3H, CH3), 2.58 (s, 3H, CH3, SR 
group), 2.70 (s, 3H, CH3, SR group), 3.29 (dd, 1H, CH2, 
2JH-H= 12.4 Hz, 
3JH-H= 6.8 Hz), 3.56 
(dd, 1H, CH2, 
2JH-H= 12.4 Hz, 
3JH-H= 6 Hz), 4.08 (m, 1H, CH allyl trans to S), 5.20 (m, 1H, 
CH allyl trans to P), 5.28 (m, 2H, CH-S and CH allyl central), 5.34 (m, 1H, CH-O), 6.14 (d, 
1H, CH=, 3JH-H= 6.4 Hz), 7.04 (m, 1H, CH=), 7.3-7.5 (m, 7H, CH=). 
13C NMR (CD2Cl2, 298 
K), : 18.1 (CH3), 18.2 (CH3), 21.0 (CH2 allyl), 21.9 (CH3), 22.0 (CH3), 24.7 (CH3, SR 
group), 24.8 (CH3, SR group), 29.5 (CH2 allyl), 30.96 (CH2 allyl), 33.1 (CH3, 
tBu), 33.5 (CH3, 
tBu), 36.6 (C, tBu), 36.8 (C, tBu), 40.1 (d, CH2, JC-P= 5.4 Hz), 56.8 (d, CH-S, JC-P= 3.2 Hz), 
85.1 (m, CH-O and CH allyl trans to S), 103.8 (d, CH allyl trans to P, JC-P= 28.6 Hz), 115.0 
(d, CH allyl central, JC-P= 7.9 Hz), 125.4-147.0 (aromatic carbons). MS HR-ESI [found 
839.2870, C47H58O3PPdS (M-BF4)
+ requires 839.2874]. 
[Pd(3-1,3-diphenylallyl)(L5b)]BF4 (64). Major isomer (57%): 31P NMR (CD2Cl2, 298 
K), : 102.8 (s, 1P). 1H NMR(CD2Cl2, 298 K), : 1.25 (s, 9H, CH3, 
tBu), 1.59 (s, 9H, CH3, 
tBu), 1.66 (s, 3H, CH3), 1.69 (s, 3H, CH3), 1.97 (s, 3H, CH3, SR group), 2.18 (s, 3H, CH3), 
2.24 (s, 3H, CH3), 2.95 (s, 3H, CH3, SR group), 2.97 (m, 1H, CH2), 3.41 (dd, 1H, CH2, 
2JH-H= 
12.4 Hz, 3JH-H= 7.2 Hz), 4.70 (m, 1H, CH-S), 4.75 (m, 1H, CH allyl trans to S), 4.85 (m, 1H, 
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CH-O), 5.46 (m, 1H, CH allyl trans to P), 6.18 (dd, 1H, CH allyl central, 3JH-H= 10.8 Hz, 
3JH-
H= 9.2 Hz), 6.36 (d, 1H, CH=, 
3JH-H= 6.0 Hz), 6.71-7.52 (m, 14H, CH=). 
13C NMR (CD2Cl2, 
298 K), : 16.9 (CH3), 17.3 (CH3), 20.7 (CH3), 20.9 (CH3), 22.5 (CH3, SR group), 24.0 (CH3, 
SR group), 31.5 (CH3, 
tBu), 32.1 (CH3, 
tBu), 36.4 (C, tBu), 36.6 (C, tBu), 37.6 (b, CH2), 53.6 
(CH-S), 80.2 (d, CH allyl trans to S, JC-P= 7.3 Hz), 80.4 (d, CH-O, JC-P= 6.8 Hz), 93.0 (d, CH 
allyl trans to P, JC-P= 21.2 Hz), 110.8 (d, CH allyl trans to P, JC-P= 8.4 Hz), 122.7-144.5 
(aromatic carbons). Minor isomer (43%): 31P NMR (CD2Cl2, 298 K), : 102.6 (s, 1P). 
1H 
NMR(CD2Cl2, 298 K), : 1.50 (s, 9H, CH3, 
tBu), 1.58 (s, 9H, CH3, 
tBu), 1.63 (s, 3H, CH3), 
1.80 (s, 3H, CH3), 2.20 (s, 3H, CH3, SR group), 2.42 (s, 3H, CH3), 2.48 (s, 3H, CH3), 3.14 (s, 
3H, CH3, SR group), 2.97 (m, 1H, CH2), 3.30 (dd, 1H, CH2, 
2JH-H= 12.4 Hz, 
3JH-H= 7.2 Hz), 
4.15 (m, 1H, CH allyl trans to S), 4.89 (m, 1H, CH-O), 5.02 (m, 1H, CH-S), 5.39 (m, 1H, CH 
allyl trans to P), 6.36 (d, 1H, CH=, 3JH-H= 6.0 Hz), 6.52 (t, 1H, CH allyl central, 
3JH-H= 9.6 
Hz), 6.71-7.52 (m, 14H, CH=). 13C NMR (CD2Cl2, 298 K), : 16.9 (CH3), 17.3 (CH3), 20.8 
(CH3), 20.8 (CH3), 22.5 (CH3, SR group), 23.3 (CH3, SR group), 30.6 (CH3, 
tBu), 31.0 (CH3, 
tBu), 36.5 (C, tBu), 36.8C, tBu), 37.6 (b, CH2), 53.5 (CH-S), 79.8 (d, CH allyl trans to S, JC-P= 
6.3 Hz), 92.3(d, CH-O, JC-P= 6.2 Hz), 103.2 (d, CH allyl trans to P, JC-P= 23 Hz), 112.1 (d, 
CH allyl trans to P, JC-P= 10 Hz), 122.7-144.5 (aromatic carbons). MS HR-ESI [found 
951.3184, C56H62O3PPdS (M-BF4)
+ requires 951.3187]. 
[Pd(3-1,3-diphenylallyl)(L5c)]BF4 (65). Major isomer (70%): 31P NMR (CD2Cl2, 298 
K), : 104.3 (s, 1P). 1H NMR(CD2Cl2, 298 K), : 1.41 (s, 9H, CH3, 
tBu), 1.63 (s, 3H, CH3), 
1.65 (s, 3H, CH3), 1.77 (s, 12H, CH3, 
tBu and CH3), 2.27 (s, 3H, CH3), 2.47 (s, 3H, CH3, SR 
group), 3.06 (s, 3H, CH3, SR group), 3.01 (m, 1H, CH2), 3.36 (dd, 1H, CH2, 
2JH-H= 12.8 Hz, 
3JH-H= 6.8 Hz), 5.01 (m, 1H, CH-O), 5.06 (m, 1H, CH-S), 5.12 (m, 1H, CH allyl trans to S), 
5.26 (d, 1H, CH allyl trans to P, 3JH-H= 10 Hz), 5.95 (d, 1H, CH=, 
3JH-H= 6.0 Hz), 6.73 (m, 
1H, CH allyl central), 6.87-7.51 (m, 14H, CH=). 13C NMR (CD2Cl2, 298 K), : 18.0 (CH3), 
18.4 (CH3), 21.9 (CH3), 22.1 (CH3), 24.4 (CH3, SR group), 25.8 (CH3, SR group), 33.8 (CH3, 
tBu), 34.2 (CH3, 
tBu), 36.7 (C, tBu), 36.9 (C, tBu), 40.0 (d, CH2, JC-P= 6.7 Hz), 56.9 (d, CH-S, 
JC-P= 2.7 Hz), 84.7 (d, CH-O, JC-P= 5.4 Hz), 88.6 (d, CH allyl trans to S, JC-P= 5.2 Hz), 101.5 
(d, CH allyl trans to P, JC-P= 25.7 Hz), 112.9 (d, CH allyl trans to P, JC-P= 8.3 Hz), 124.7-
146.9 (aromatic carbons). Minor isomer (30%): 31P NMR (CD2Cl2, 298 K), : 107.1 (s, 1P). 
1H NMR(CD2Cl2, 298 K), : 1.64 (s, 9H, CH3, 
tBu), 1.72 (s, 9H, CH3, 
tBu), 1.74 (s, 3H, CH3), 
1.82 (s, 3H, CH3), 2.31 (s, 3H, CH3), 2.33 (s, 3H, CH3), 2.38 (s, 3H, CH3, SR group), 2.60 (s, 
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3H, CH3, SR group), 3.01 (m, 1H, CH2), 3.47 (dd, 1H, CH2, 
2JH-H= 12.8 Hz, 
3JH-H= 6.8 Hz), 
4.85 (d, 1H, CH-S, 3JH-H= 5.6 Hz), 5.21 (m, 1H, CH allyl trans to S), 5.51 (m, 1H, CH-O), 
5.70 (d, 1H, CH allyl trans to P, 3JH-H= 10 Hz), 6.00 (d, 1H, CH=, 
3JH-H= 6.0 Hz), 6.58 (m, 
1H, CH allyl central), 6.87-7.51 (m, 14H, CH=). 13C NMR (CD2Cl2, 298 K), : 18.2 (CH3), 
18.3 (CH3), 21.9 (CH3), 22.0 (CH3), 24.2 (CH3, SR group), 26.1 (CH3, SR group), 32.8 (CH3, 
tBu), 34.1 (CH3, 
tBu), 36.6 (C, tBu), 36.7 (C, tBu), 39.6 (d, CH2, JC-P= 7.5 Hz), 58.1 (d, CH-S, 
JC-P= 2.5 Hz), 86.7 (d, CH-O, JC-P= 7.5 Hz), 95.0 (d, CH allyl trans to S, JC-P= 5.4 Hz), 95.9 
(d, CH allyl trans to P, JC-P= 23.7 Hz), 113.0 (d, CH allyl trans to P, JC-P= 9.1 Hz), 124.7-
146.9 (aromatic carbons). MS HR-ESI [found 951.3182, C56H62O3PPdS (M-BF4)
+ requires 
951.3187]. 
4.12. Study of the reactivity of the [Pd(3-allyl)(L))]BF4 with sodium dimethyl 
malonate by in situ NMR29  
A solution of in situ prepared [Pd(3-allyl)(L)]BF4 (L= phosphite-thioether, 0.05 mmol) in 
CD2Cl2 (1 mL) was cooled in the NMR at –80 C. At this temperature, a solution of cooled 
sodium dimethyl malonate (0.1 mmol) was added. The reaction was then followed by 31P 
NMR. The relative reaction rates were calculated using a capillary containing a solution of 
triphenylphosphine in CD2Cl2 as external standard. 
 
4.13. Computational details 
Geometries of all transition states and intermediates were optimized using the Gaussian 09 
program,30 employing the B3LYP31 density functional and the LANL2DZ32 basis set for 
palladium and the 6-31G* basis set for all other elements.33 Solvation correction was applied 
in the course of the optimizations using the PCM model with the default parameters for 
dichloromethane.34 The complexes were treated with charge +1 and in the single state. No 
symmetry constraints were applied. Normal mode analysis of all transition states revealed a 
single imaginary mode corresponding to the expected nucleophilic attack of the nucleophile to 
one of the two allylic termini carbons. The energies were further refined by performing single 
point calculations using the above-mentioned parameters, with the exception that the 6-
311+G**35 basis set was used for all elements except palladium, and by applying dispersion 
correction using DFT-D336 model. All energies reported are Gibbs free energies at 298.15 K 
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